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Abstract 
Concussion injuries have gained the attention of healthcare providers because of the 
effects that persistent reoccurring symptoms, associated with the injury, can have on normal 
functioning.  As such, there is a recognized need to establish appropriate pre-injury measurements 
of individuals at risk for concussion so that healthcare providers can establish a more accurate 
diagnosis, management and treatment post concussion. 
The purpose of the present study was to assess the stability of heart rate variability 
(HRV) and contralateral auditory suppression of transient evoked oto-acoustic emissions (CAS 
TEOAE) as objective measures for the assessment of concussion.  
The study was conducted in three phases: 1) to assess the stability of the methodologies 
related to measuring  (n=25); 2) to determine the relationship between the clinical measures 
(HRV & CAS TEOAE) with psychological measures (n=75) (DASS-21 and PASS-20); 3)to 
assess to response profile following injury on a case study basis (n=1).  
A test-retest research design was used to establish the stability of the clinical methods.  
Twenty-five university-aged individuals were assessed on HRV and CAS TEOAE on two 
separate occasions. The McNemar chi-square of symmetry was used to establish the measure of 
difference between day 1 and day 14, while the kappa statistic of agreement was used to assess 
the measure of agreement between the variables.  
No significant differences were found between test-retest observations for selected measures of 
CAS TEOAE (Y1414, Diff14141, X2000, SUM2000) and selected measures of HRV (RMSSD 
and mean HR).  In addition, two variables from each of the HRV test and the CAS TEOAE test 
showed significant agreement between the test-retest days.   
As part of phase 2 significant relationships, observed independently between HRV and 
CAS TEOAE were quantified with subscales of the DASS-21 and PASS-20 in a cohort of 
university varsity athletes.  Relationships with the subscale were established using the Spearman 
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Correlation Coefficient both within the entire sample as well as within the sub-cohorts based on 
concussion history. The relationships in the total population were not present in those who 
reported a previous history of concussion, indicating a change in psychological measures and 
their predictability of HRV.  
In phase three, the case study of one athlete showed notable decreases in HRV (a 
condition of injury) and a decrease in CAS TEOAE functioning in the immediate post injury 
state, with a noted increase in both measures during the recovery phases.  These results support 
the need for further study of HRV and CAS TEOAE as objective measures of concussion.  
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Glossary of Terms 
Autonomic Nervous System- the division of the nervous system that encompasses 
efferent neurons that synapse with and regulate the function of internal organs and 
other structures not under voluntary control. (Stanfield, 2013) 
Basilar membrane-membrane in the cochlea of the inner ear that separates the scala 
tympani from the scala media (Stanfield, 2013) 
Cochlea- A closed fluid filled spiral-shaped structure in the inner ear that contains the 
receptor cells for hearing (Stanfield, 2013) 
Coefficient of variance- measures the variability of a series of numbers independent of 
their unit of measurement (Abdi, 2010) 
Concussion- a complex pathophysiological process affecting the brain, induced by 
biochemical forces (McCrory, 2013) 
Contralateral Acoustic Suppression of Transient Evoked Oto-Acoustic Emissions 
(CAS TEOAE)- the slight depression of OAE level caused by broadband noise in the 
contralateral ear (Kemp, 2002) 
Contralateral-referring to ascending and descending pathways that are on the side 
opposite their origin (Stanfield, 2013) 
Depression Anxiety Stress Scale (DASS)- a 21 or 43 item self report questionnaire to 
measure different symptoms of depression, anxiety and stress (Lovibond & Lovibond, 
1995)  
Endolymph- fluid found in the scala media of the cochlea, and has a high 
concentration of potassium ions and a low concentration of sodium ions (Stanfield, 
2013) 
Frequency Domain- measurement of HRV using spectral analysis to assess different 
measurements (Task Force, 1996) 
Heart Rate Variability (HRV)- Oscillations in the interval between consecutive heart 
beats (Task Force, 1996) 
Ipsilateral- referring to ascending and descending pathways that are on the same side 
as their origin (Stanfield, 2013) 
Kappa z-score-a quantitative measure of the magnitude of agreement between 
observations (Viera & Garrett, 2005) 
McNemar Chi-Square- a statistic that enables the researcher to evaluate the 
concordant pairs while adjusting for the discordant pairs and asses if the two sets of 
data are significantly different  (McNemar, 1947; McNemar, 1969) 
Organ of Corti-the sensory organ for sound; located on top of the basilar membrane in 
the cochlea (Stanfield, 2013) 
Otoacoustic Emissions (OAE)- sounds that arise in the ear canal when the tympanum 
receives vibrations transmitted backwards through the middle ear from the cochlea. 
They occur as a by product of a cochlear mechanism called the cochlear amplifier 
(Kemp, 2002) 
Outer Hair Cells- the cells with stereo cilia receptor cells for hearing and equilibrium 
(Stanfield, 2013) 
Pain Anxiety Symptoms Scale (PASS)- a questionnaire that assesses four factorially 
distinct components of pain-related anxiety: cognitive, fear, escape/avoidance, 
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physiological. (Abrams et al, 2007) 
Perilymph-fluid found in the scala vestibuli and scala tympani of the cochlea in the 
inner ear. (Stanfield, 2013) 
Reliability- the consistency of a test or measurement (Weir, 2005) 
Scala Media-fluid filled duct in the cochlea also known as the cochlear duct 
Scala Tympani-fluid filled duct in the cochlea also known as the tympanic duct 
Scala Vestibuli-fluid filled duct in the cochlea also known as the vestibular duct 
Signal Transduction- the process by which the binding of a chemical messenger to 
receptors brings about a response in a target cell (Stanfield, 2013) 
Stereo cilia- hair like projections on the upper surface of hair cells in the inner ear that 
move in response to sound vibrations or acceleration of the head (Stanfield, 2013) 
Sympathovagal Balance-term used to described the dual, opposing effects of the 
sympathetic and parasympathetic nervous systems on the sinus node (Goldberger, 
1999) and is best defined as the ratio of LF to HF (Eckberg, 1997) 
Tectorial membrane-membrane in the organ of Corti in which the tips of stereo cilia 
are embedded (Stanfield, 2013) 
Time Domain- Measurement of HRV using the normal-to-normal interval and 
different statistical formulae (Task Force, 1996) 
Vagus Nerve- major parasympathetic nerve that originates in the medulla oblongata 
and innervates much of the viscera; cranial nerve X (Stanfield, 2013) 
Vestibular membrane-membrane in the cochlea of the inner ear that separates the 
scala vestibuli from the scala media (Stanfield, 2013) 
Vestibulocochlear Nerve- nerve that contains the afferents for hearing and 
equilibrium; cranial nerve VIII (Stanfield, 2013) 
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Chapter 1 
Introduction 
1.1 Background 
Concussion and issues related to post concussion events have become prominent in North 
American society, specifically within cohorts of active individuals. In the past, 
concussions have been an accepted and common event within contact sports, especially 
those with frequent body contact between players or the playing environment. If the 
fundamental principles of participating in sport are to promote health and to inspire 
physical activity, then concussion injuries may compromise such participation. 
 Concussion, which is described as a traumatically induced disturbance of brain 
function, is classified as a subtype of mild traumatic brain injury (Harmon et al. 2013). 
 Depending on the magnitude and the mechanics of the injury —a linear or rotational 
impact to the head or body —concussion can cause bruising, and in severe cases nerve 
damage, to brain tissue. This type of injury is normally transient, meaning that a 
concussion is not expected to persist for a prolonged period of time following the injury. 
The signs and symptoms of concussion can manifest immediately after an injury, but in 
some cases may not be observed for at least eight hours after the incident (McCrory et al. 
2013). Concussion has gained attention in the media because it is not only linked to acute 
injury, but because it has also been linked to depression, diminished sensorimotor 
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functioning, and early stage dementia, among athletes (Cantu, 2007; Guskiewicz et al, 
2005). 
As concussion injuries become prominent in the popular media and are the cause 
of persistent reoccurring symptoms which detract from proper functioning, the diagnosis, 
management and treatment of concussed athletes has gained increasing attention. 
Moreover, recognizing the relevance of the concussion injury on long-term consequences 
following involvement in sport has mediated the process of return to sport decision 
making among officials, coaches and players across the spectrum of physical activity. 
1.2 Purpose 
The present study measured the relationships between baseline estimates of 
physiological and neuropsychological functioning that may be influenced by concussion 
injury. Specifically, the primary purpose of the present study is to investigate the test-
retest reliability of heart rate variability (HRV) and contralateral auditory suppression of 
transient evoked oto-acoustic emissions (CAS TEOAE) as objective measures to assess 
concussion. The secondary purpose of the present study is to evaluate the psychological 
measures from the PASS-20 and DASS-21 for relationships with the objective measures 
of HRV and CAS TEOAE as predictive variables 
Finally, the present study sought to evaluate the case study response profile for a 
university aged varsity athlete on the objective measures of HRV and CAS TEOAE. 
Within this aim we, provide case study comparisons for athletes that were concussed or 
were suffering post concussion syndrome, to determine their recovery profile, in relation 
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to the injury—recovery hypothesis (Appendix A). Montelpare developed the injury 
recovery hypothesis in 2013. It depicts the change in a multi modality baseline 
assessment following a concussion injury. The key to the injury recovery hypothesis is 
the instability in the first few days following injury and the subsequent return to or near 
baseline scores. The purpose of the injury recovery hypothesis is to asses the time, in 
days, to return to baseline for HRV and CAS TEOAE following concussion, compared to 
other concussion testing methods. 
1.3 Rationale 
Current concussion testing methods which include the balance error scoring 
system (BESS), the sport concussion assessment test (version 3; SCAT3), and various 
neuropsychological tests (McCrory et al, 2009) are currently used following the 
suspected concussion injury to assess and establish quantitative estimates of the injury. 
 Such methods have been tested and shown to be statistically stable in selected cohorts of 
non-concussed healthy individuals (Lovell et al. 2006), but with several limitations 
(McCrory et al, 2009).  For example, Valovich Perrin & Gansneder  (2003) identified a 
practice effect in participants with repeated administration of the BESS, and McCrory 
and coworkers indicated that the BESS has limited capacity to identify postural stability 
deficits only up to 72 hours following an injury (2009). A modified version of the BESS 
is recommended for use in the SCAT-3. However, the test is limited to testing balance on 
a flat surface, and no intra-rater or inter-rater reliability has been established for this 
modified use of BESS (Harmon et al, 2012).  
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Likewise, neuropsychological testing also has demonstrated limitations. 
 Symptom reporting is a determining factor in return to play decisions. However, 
symptom resolution may not always indicate neurocognitive recovery (Harmon et al, 
2012).  Previous research by McCrea et al, showed that athletes were unwilling to report 
concussion symptoms; 40% of athletes felt that they were concussed but didn’t report the 
injury.  The common reason for non-reporting was attributed to the belief that they would 
lose playing time (McCrea et al, 2004). Johnson, Kegel & Collins (2011) identified that 
both extrinsic and intrinsic factors including fatigue, distractions, mood disorders and 
history of concussion, can influence scores on neurocognitive tests and symptom 
reporting. 
In most sports environments the typical baseline test for concussion is the 
neuropsychological test. It is therefore suggested that subcortical tests which measure 
neural processing activity of specific cranial nerves and efferent nerve innervations of the 
outer auditory hair cells will provide more precise and robust estimates that are stable for 
detecting and tracking the concussion condition. The use of subcortical tests as used in 
the present research study do not require the participant’s active input or extended time 
commitments. Specifically HRV and CAS TEOAE as non-invasive, objective measures 
for vagal and auditory nerve activity is hypothesized to be a more comprehensive 
approach that we will lead to more accurate testing methods and return to play analysis, 
but eliminating self-reporting of symptoms and manipulation of testing. The cranial nerve 
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pathways that will allow this assessment are outlined in depth in the review of literature 
in chapter 2.  
1.4 Research Hypothesis 
Heart rate variability and contralateral auditory suppression of transient evoked oto-
acoustic emissions will be assessed in three stages, first for stability, secondly against 
psychological measures of the Depression Anxiety and Stress Scale (DASS-21) and the Pain 
Anxiety Symptom Scale (PASS-20) for emotional interactions and finally on a case study 
basis to assess the injury response profile following a concussion. 
1. It is hypothesized that HRV and CAS TEOAE will be stable measurements as 
assed by different variables for each test respectively. 
2. It is hypothesized that there will be a statistical relationship between CAS and 
HRV, and between HRV and DASS-21, and between DASS-21 and PASS-20. It 
is expected that there will be no relationship between CAS and DASS, and CAS 
and PASS-20. 
3. It is hypothesized that there will be a significant difference between a healthy 
university aged score and a concussed score on HRV and CAS TEOAE.  
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Chapter 2 
Literature Review 
This section will first explore HRV and CAS TEOAE as objective measures of cranial 
nerve activity Then, background information on concussion and the potential use of HRV and 
CAE TEOAE to evaluate concussion will be presented, followed by the explanation of the 
DASS-21 and PASS-20 as potential relationships with the objective measures. 
2.1 Heart Rate Variability 
The physiological phenomenon of heart rate variability (HRV) is defined by the 
European Society of Cardiology and by the North American Society of Pacing 
Electrophysiology as an oscillation of the intervals between consecutive heart beats (Task 
Force, 1996).  HRV is considered a clinically relevant predictor of cardiac dynamics and 
potential indicator for sudden cardiac death. Hon and Lee (1965) first noted the clinical 
relevance of HRV by measuring the changes in beat-to-beat intervals as a precursor to 
fetal distress. HRV has since been used as an analytical tool for patients with chronic 
heart failure, hypertension, diabetes, and cardiac transplantation (Task Force, 1996; 
Bravi, Longtin & Seely, 2011; Valencia et al, 2009). HRV has also been suggested as a 
clinical tool in assessing the severity mild traumatic brain injury-concussion (Goldstein et 
al, 1998; Lagos, Bottiglieri, Vaschillo & Vaschillo, 2012). The reason for using HRV in 
this application will be described in the following sections as it pertains to it’s indirect 
measurement of vagal tone and the application of vagal tone on health outcomes. 
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2.1.1 Measurements 
Measurements for HRV are divided into two domains, the time domain and the 
frequency domain. Typical variables used in the assessment of HRV are listed in Table 
3.1. Despite the mathematical simplicity in the analysis of both time domain and 
frequency domain assessments, the measures of HRV are considered useful in clinical 
applications (Bravi, Longtin & Seely, 2011).  
Frequency domain measurements are derived using fast Fourier transformations 
(FFT) and autoregressive modeling (Task Force et al, 1996, Tarvainen et al, 2013). Based 
on the frequency domain measurements there is power spectral analysis. Power spectral 
analysis is divided into the following bands: very low frequency (VLF) ranging from 
0.003 Hz to 0.04 Hz, low frequency (LF) ranging from 0.04 Hz to 0.15 Hz and high 
frequency (HF) ranging from 0.15Hz 0.4 Hz. Frequency domain measures are reported in 
ms2 (Task Force, 1996; Bravi, Longtin & Seely 2011; Nunan et al, 2009). Low and high 
frequency HRV measures can also be reported in normalized units (n.u.). Normalized 
units emphasize the two aspects of the autonomic nervous system: SNS and PNS. 
Normalized units provide a quantitative estimate of the balance between sympathetic and 
parasympathetic activity (Task Force, 1996; Nunan et al, 2009). Kubios (Finland) is a 
university based research group, which provides free software to estimate HRV across 
frequency and time domains. In particular the Kubios software uses a spectral analysis 
based on Welch’s periodogram and autoregressive modeling. The spectrum estimates are 
obtained by averaging the FFT of five-minute segments within a series of cardiac cycles 
(Tarvainen et al, 2013). Using a short-term (five minute) analysis the researcher can 
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interpret total power (VLF+LF+HF) as a descriptive measure of HRV dynamics. 
However, it is recommended that VLF as a single measure is inconclusive and should not 
be used to describe HRV dynamics (Task Force, 1996; Nunan et al, 2010). Frequency 
domain measurements are associated with sympathetic and parasympathetic drive, which 
causes the HRV response. The LF band has been associated with both sympathetic and 
parasympathetic drive, whereas the HF band reflects cardiac vagal control 
 (parasympathetic activity) and is associated with respiratory rhythm (Task Force, 1996; 
Moak et al, 2008, Nunan et al, 20010; Zhang, 2007). From the power spectrum analysis 
the ratio of LF to HF is also computed.  The computation of the LF/HF ratio is of critical 
importance as it is the measure, which is used to quantify the sympathovagal balance 
(Task Force, 1996; Eckberg, 1997; Pagani et al, 1997). 
Time domain measurements are based on the normal ECG tracing of a series of 
cardiac cycles. One measure is the normal-to-normal (NN) interval, which is the distance 
between consecutive R waves in a normal PQRS tracing. The R wave represents the long 
wave of ventricular contraction and is representative of the electrical activity required for 
ventricular ejection. Ventricular ejection fraction is driven by metabolic needs, and 
therefore will adjust to sympathetic, parasympathetic and hemodynamic loading in 
normal physiological functioning (Stanfield, 2013). Several measurements are derived 
from the computation of the NN interval including the mean heart rate (HR) and the 
mean time between each beat (represented as the mean RR). Time domain measurements 
are derived from the statistical evaluation of the ECG tracing for example the standard 
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deviation of the NN interval (represented as the SDNN) reflects the cyclic components of 
variability and is an indicator of overall HRV (Task Force, 1996). The root mean square 
of the standard deviation (represented as RMSSD) evaluates the mean squared difference 
of successive NN intervals and is associated with indications of parasympathetic outflow 
(Task Force, 1996; Kleiger, Stein, Bosner & Rottman, 1992). RMSSD is highly variable 
and suspect to changes based on age and physical training (Ori, Weiss, Sayhouni; Singer, 
1992; Puig et al, 1993). The proportion of NN intervals differing by more than 50ms 
divided by the number of total NN intervals, known as the pNN50, estimates high 
frequency variations in heart rate and is considered a good overall indicator of HRV 
(Task Force, 1996). Combining frequency and time domain measurements provides a 
comprehensive assessment of HRV (Bravi, Longtin & Seely, 2011; Task Force, 1996; 
Eckberg, 1997). 
Despite the ability of theses measures to assess HRV, there exists an intrinsic 
problem with overall HRV measurement. HRV is a measure of variance and therefore 
both intra-individual and interindividual comparisons may not be stable in successive 
trials (Fagard, Pardaens & Staessen, 1999). According to Bravi, Longtin & Seely (2011) 
it may be more accurate to assess HRV within an individual rather than between 
individuals to ensure accurate assessments. It should also be noted that there are sex, age 
and exercise specific differences in HRV measurements. In a retrospective study 
conducted by Zhang (2007) the researchers observed that heart rate, RR interval, HF, LF 
norm, HF norm and LF/HF were each significantly different between males and females. 
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 Nunan et al (2010) also noted a similar difference across sex with females demonstrating 
lower values in RMSSD, while males had lower LF and HF values. It was also noted that 
with increasing age there was a concomitant decrease in total power, LF and HF 
measures (Zhang, 2007). Highly trained individuals showed increased values of cardiac 
vagal modulation including mean HR, HF, and RR interval (Puig et al, 1993; Shin et al, 
1997; Sandercock, Bromley & Brodie, 2005)     
Heart rate variability has also been used to as a research tool with psychological 
assessment. Sympathetic and parasympathetic adjust to mediate emotional coping and are 
the controlling factors for HRV. Physical and mental stress has an influence both of these 
systems with an increase in sympathetic drive and a decrease in parasympathetic control 
 (Hughes & Stoney, 1999; Visnovcova, Calkovska & Tonhajzerova, 2013). In a stressful 
situation the sympathetic nervous system is activated and an increase in catecholamine 
release leads to an overall increase in heart rate (Gorman & Sloan, 2000), changing the 
HRV measurements. Stress, depression and pain are all thought to have similar effects on 
HRV, specifically a decreased on HF as is a measure of parasympathetic activity (Hughes 
& Stoney, 1999; Task Force, 1996). Hughes & Stoney found that participants scoring 
higher on the Beck Depression Index had significantly different HF responses to stress 
than their matched controls with lower scores (2000). Tousignant-Laflamme and 
coworkers found that males and females showed different heart rate response as a 
response to pain, where a positive relationship between pain and anger existed in males 
but was not statistically significant in females (Tousignant-LaFlamme, Rainville & 
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Marchand, 2005) It has also been shown that HRV is positively associated with pain 
(Appelhans & Leuken, 2006). Stress has also been associated with HRV (Sloan et al, 
1994) and patients with anxiety disorder had lower HF at rest and during worry than a 
control group (Thayer, Friedman & Borkovec, 1996). Dishman and coworkers also noted 
an inverse relationship between HRV and recent stress (Dishman et al, 2000).  
2.1.2 Sympathovagal Balance 
The sympathetic nervous system (SNS) and parasympathetic nervous system 
(PNS) regulate the cardiac cycle. Having two opposing systems allows the cardiac cycle 
to adapt to intrinsic and extrinsic changes in stressors in the body and maintain 
homeostasis. The SNS regulation of cardiac output via the sympathetic cardiac nerve, 
stems from thoracic nerves T1- T4,  and has receptors in the sino atrial node (SA node), 
atrioventricular node (AV node) and the ventricular myocardium (Stanfield, 2013). The 
SNS regulation is activated and maintained by the release of epinephrine and 
norepinephrine followed by a signal cascade that results in an acceleration of diastolic 
depolarization (Stanfield, 2013 &Task Force, 1996) resulting in an increased heart rate 
consistent with the ‘fight or flight response’. 
PNS regulation arises from the vagal nerve and has receptors in the SA node and 
in the AV node (Stanfield, 2013).   PNS regulation is controlled by the vagal nerves 
release and complete expression of acetylcholine and results in a slow diastolic 
depolarization (Task Force, 1996; Eckberg, 1997). Consistent with the ‘rest and digest’ 
response, parasympathetic and vagal tone is high in resting conditions (Goldberger, 
  
 
24 
1999). The regulation of the cardiac cycle is a result of the balance between the SNS and 
the PNS, through the vagal nerve, termed sympathovagal balance. It is commonly 
accepted and understood that efferent vagal activity can be indirectly quantified with 
spectral analysis of the high frequency band, from 0.4Hz-0.15Hz, elaborated on below 
(Task Force, 1996; Berntson et al, 1997; Pagani et al, 1997). However, the quantification 
of SNS in HRV activity is less accepted and more controversial. It is argued that the low 
frequency band (0.04-0.15Hz) reflects SNS regulation of the SA node (Berntson et al, 
1997) or a combination of both SNS and PNS (Task Force, 1996; Goldberger, 1997). The 
relationship of SNS and PNS, the sympathovagal balance, can be shown through the 
LF/HF ratio or the average RR interval which is ventricular depolarization, or the mean 
time between each beat of the heart.  
2.2 Otoacoustic Emissions 
Otoacoustic emissions (OAE) are physiologically produced response to sound 
when the tympanum receives vibrations backwards from the cochlea through the middle 
ear(Kemp, 2002). OAEs originate from the cochlea outer hair cells and reflect back 
through the middle ear and ear canal, as a by-product response from the cochlear 
amplifier (Kemp, 2002). It is important to understand that OAE measurement is not a test 
of hearing; it is a test of cochlear and peripheral auditory system function (Kemp, 1978; 
Kemp 2002). The OAE response is a pre-neural cochlea response, as the basilar 
membrane of the cochlea vibrates in response to sound waves. These sound waves are 
then sent back through the ear canal is a result of the reflection of a sound wave from the 
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outer hair cells in the cochlea and are considered a naturally occurring imperfection 
(Abdala & Visser-Dumont, 2003; Kemp, 2002). The hearing pathway as described by 
Standfield (2013) presented below in Figure 2.1 explains the signal transduction of a 
sound wave and it interactions with the cochlea, and specifically the organ of Corti and 
the outer hair cells.  
 
Figure 2.1 Hearing Pathway described from Stanfield (2013).  
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The OAE arises as a reflection of the oscillations from the traveling sound wave 
of the basilar membrane and the bending of the outer hair cells of the organ of the Corti. 
The OAE reflects back through the ossicles, tympanic membrane and then the ear canal 
where it can be picked up by a very sensitive microphone (Kemp, 2002; Stanfield, 2013).  
2.2.1 Distortion Product and Transient Evoked Otoacoustic Emissions 
In the field of OAE research, there are two main testing mechanisms for evoking 
the OAE response: the distortion product (DPOAE) stimuli and the click or transient 
evoked (TEOAE) stimuli. A DPOAE test uses two different pure tones (f1, f2) that are 
presented in the ear canal at the same time (Abdala & Visser-Dumont, 2003). The 
DPOAE technique is more suited for advanced clinical uses o, but the analysis is 
complex leading to difficulties in interpreting results (Kemp, 2002) Comparatively 
TEOAEs are tested using one non-linear click stimulation at multiple frequencies 
(Hatzopoulos, Pertucelli, Morlet & Martin, 2003). The TEOAE technique is more 
sensitive to cochlear changes that are quantifiable by the waveform response and is 
primarily recorded in the speech frequency range of 1 to 4 kHz (Kemp, 2002). 
2.2.2 Spontaneous Otoacoustic Emissions 
One type of imperfection of the cochlear OAE response is a spontaneous OAE 
(SOAE). Spontaneous OAE are essentially when a pure tone is produced in the absence 
of a stimuli and it arises from positive feedback of a traveling sound wave (Abdala & 
Visser-Dumont, 2003). The positive feedback leads to self-oscillation and wave energy, 
which would typically be absorbed, that stimulates the outer hair cells leading to an 
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unprovoked OAE (Kemp, 2002). The recording of SOAEs is well recognized and 
mechanisms for their function in agreed upon. However, the exact effect they have on the 
recording of DP or TEOAEs is not entirely understood (Bright, 2002; Killan, Lutman & 
Montelpare, 2011). It has been hypothesized that SOAEs play a role in tinnitus or can be 
perceived as tinnitus, which would give further insight into its clinical relevance, but it 
has not been definitively investigated (Chery-Croze, Truy & Morgan, 1994; Kemp, 
2002). 
2.2.3 Contralateral Acoustic Suppression of Transient Evoked Otoacoustic 
Emissions 
Previous research has established that the TEOAE response is suppressed (i.e. the 
linear amplitude of the response is decreased) by the presence of contralateral broadband 
(high frequency) noise (Collet et al, 1990; Hood et al, 1995).  This process is referred to 
as the contralateral acoustic suppression of TEOAE (CAS TEOAE). The process occurs 
in individuals who demonstrate a properly functioning auditory nerve pathway. Collet 
and coworkers (1990) hypothesized that the suppressive effect could evaluate the efferent 
nerve pathway and its function. Kemp (2002) suggested that the significance of the 
presence and absence of the contralateral suppression response may clarify neural 
audiological pathologies (Harkrider & Bowers, 2009). 
The mechanism of contralateral suppression is facilitated by the olivocochlear 
reflexes (lateral and medial) of both the ipsilateral and contralateral ears: where ipsilateral 
is defined as when the ascending and descending pathways are on the same side as their 
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origin, i.e. the ear being tested with TEOAE, and contralateral as when the ascending and 
descending pathways are on the opposite side as the origin, i.e. the untested ear 
(Stanfield, 2013). There are two main hypotheses about the exact mechanism of 
contralateral suppression presented by Giraud et al (1995). They hypothesized that the 
acoustic reflex leads to the contraction of the stapedius muscle and that will decrease the 
OAE response, or that contralateral suppression involved direct cochleo-cochlear 
interaction via efferent nerve pathways (1995). Testing various populations with various 
auditory impairments the concluded that the medial olivocochlear pathway is involved in 
contralateral suppression, as suppression persisted in participants with Bell’s Palsy, 
where the middle ear reflexes are lost, but not in participants with vestibular neurotomy, 
where the olivocochlear fibres are cut (Guiard et al, 1995). 
As stated above, when the outer hair cells bend in response to oscillation of the 
organ of the Corti, hyperpolarization of the hair cell leads to neurotransmitter release in 
the inner hair cell and the action potential in the auditory nerve (Stanfield, 2013). The 
medial olivocochlear bundle synapses directly into the outer hair cells, and the wave 
stimulation activates an OAE and the efferent nerve pathway. When this happen 
simultaneously in the ipsilateral and contralateral ears, the stimulus in the contralateral 
ear will travel the medial olivocochlear pathway and suppress the OAE in the ipsilateral 
ear (Murdin & Davies, 2008). This type of suppressive effect has been shown in all three 
types of OAEs mentioned above, DPOAE (Guinan, 2006), TEOAE (Collet, Veuillet, 
Bene & Morgan, 1992) and SOAE (Mott, Norton, Neely & Warr 1989). 
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To best record the suppressive effect the clinical testing has used TEOAE, as it is 
easier to facilitate at one frequency compared to the two frequencies used for DPOAE 
testing (Murdin & Davies, 2008) However, there has been reported large interindividual 
and intra-individual variability in term of suppression values of TEOAEs (Collet et al, 
1994; Giraud et al, 1995; Murdin & Davies, 2008). Giraud and co workers found mean 
suppression values of TEOAE in healthy individuals to be 2.47 dB (SD1.67 dB) (1995). 
De Ceulaer et al found a mean suppression of TEOAEs to be 1.52 dB (SD 1.09) at a 
stimulus level of 12 dB threshold (2001). Murdin & Davies reported a normal 
suppression cut off to be 0.7 dB (2008). The effect of subject task during the testing for 
contralateral suppression has also been noted by De Boer & Thornton, where participants 
who focused on arbitrary tasks, such as reading or watching a muted video rather than 
focusing on the presented stimulus had higher suppression scores (2007). Harkrider & 
Bowers also reported on this phenomenon, when attention was paid either the ipsilateral 
or contralateral stimulus the suppression was reduced in normal hearing adults (2009).  
2.3 Concussion 
Concussion is a type of mild traumatic brain injury that involves a complex 
physiological process affecting the brain (Harmon et al, 2012; McCrory et al, 2013). 
Concussion can be caused by a direct blow to the head or neck, or an indirect blow to the 
body causing force on the head (McCrory et al, 2013). Concussion is a rapid onset injury 
that can have symptoms appearing either immediately or after several hours or even days 
following the injury. Concussion is also described as a transient injury, because it is not 
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expected to last for a prolonged period of time (Harmon et al, 2012). There are several 
symptoms associated with concussion including nausea, vomiting, headache, dizziness 
and sensitivity to noise and light. Loss of consciousness is generally thought to coincide 
with concussion, however it is not a necessary condition of concussion as noted by 
Guskiewicz, Weaver, Padua & Garrett who indicated that as high as ninety percent of 
concussions do not results in loss of consciousness (2000). 
Reports of concussion have become more widespread in the media, and therefore 
the diagnosis and treatment of concussion has become a growing field. The standard post 
injury assessment is called the Sport Concussion Assessment Tool, or SCAT III, 
developed from the 4th annual Consensus Meeting on Concussion in Sport (McCrory et 
al, 2013). The SCAT has a variety of assessment tools including a symptom reporting 
scale, immediate memory test, modified balance error scoring system (BESS), cognitive 
assessment, Maddock score, and the Glasgow coma scale. The SCAT version 3 is 
suitable for youth’s aged 13 and over (McCrory et al, 2013).  One difficulty with 
concussion diagnosis is the unwillingness of athletes reporting their injuries. McCrea, 
Hammeke, Olsen, Leo & Guskiewicz noted that forty percent of concussed athlete failed 
to report their injury  (2004).  Further, many athletes report symptoms they may not 
realize are associated with a concussion (Delaney, Lacroix, Leclerc & Johnston 2002). 
Lovell et al reported that healthy women report more symptoms than healthy men at 
baseline (2006). The reluctance of athletes to report symptoms and especially those 
related to concussion is a problem as its diagnosis and return to play protocol is reliant on 
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symptom reporting. A more objective measure of concussion and recovery could help 
eliminate the weight on symptom reporting as a diagnostic tool. 
There is also an importance in accuracy of baseline testing, as there are several 
confounding factors including sex, age, sport type, and previous medical conditions that 
make sideline testing difficult without a baseline value to compare to (Harmon et al, 
2013). The return to play protocol outlined by Harmon et al (2013) and McCrory et al. 
(2013) is an individual approach where the athlete needs to be asymptomatic at rest, 
before beginning a gradual increase in physical activity. If at any point during the return 
to activity the athlete becomes again symptomatic the athletes must wait until he or she is 
asymptomatic and then begin the process again. Having an athlete return to play before 
completing the gradual return to play protocol, or while they are still symptomatic puts 
them at risk for second impact syndrome. Although second impact syndrome is rare, it 
involves a second blow to the head, or concussion, before the previous concussion is 
completely healed or repaired and can be fatal (Bey & Ostick, 2009). Therefore proper 
return to play monitoring is crucial.  
Concussion is a prevalent injury in the sporting community. In a three-year 
retrospective analysis across ten different sports mild traumatic brain injuries accounted 
for 5.5% of total injuries (Powell & Barber-Foss, 1999). American football has the 
highest prevalence of concussion (Powell & Barber-Foss, 1999) and across sports female 
athletes are at a higher risk than males in the same sports (Dick, 2009). For example: 
female soccer and basketball players are at a significantly higher risk compared to their 
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male counterparts based on reported concussions from the NCAA (Covassin, Swanik & 
Sachs, 2003). It is also noted that there is a higher incidence of reported concussion in 
game situations compared to practice regardless of sex or sport (Covassin, Swaink, & 
Sachs, 2003) 
2.3.1 Concussion and Heart Rate Variability 
Goldstein et al first presented early evidence of a relationship between mild 
traumatic brain and cardiac dynamics injury in 1998. These researchers showed that 
concussion injury had an adverse effect on the electrophysiology of the coronary system. 
Specifically they found an inverse association between heart rate and a neurological 
injury, which demonstrated direct effects between the autonomic nervous system and 
cardiovascular dynamics. This finding prompted more research into the apparent 
relationship between concussion and HRV. 
Gall, Parkhouse & Goodman (2004) measured HRV using the frequency domain 
variables in concussed participants versus a group of age-matched controls, while at rest 
and during a short exercise test. They found no significant difference in any of the 
variables at rest, but reported a statistically significant difference in the RR interval, high 
frequency and low frequency during exercise when concussed participants were 
compared to controls (Gall, Parkhouse & Goodman, 2004).  They also concluded that 
patients with sport related concussions recovered within seven to ten days of the injury 
while non-athletes could require up to three months to recover. The decline in LF and HF 
values was consistent with the findings Goldstein et al (1998). La Fountaine, et al (2009) 
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used approximated entropy (ApEn) based on the evaluation of the signal from the ECG t 
describe cardiac dynamics. In a subsequent study La Fountaine et al (2011) investigated 
the variability of successive QT intervals in concussed participants versus matched 
controls. Although the researchers observed a higher QT interval 48 hours following 
injury, there was no statistically significant difference in the concussed participants and 
their matched controls. However, La Fountaine’s studies evaluated 3 concussed 
participants each, leaving room for large variability and decreased testing power (La 
Fountaine, Gossett, De Meersman & Bauman, 2011).  All researchers concluded the link 
between cardiovascular functions, autonomic nervous system and concussion existed but 
with such small sample sizes it was difficult to infer theses results to a larger population.  
 Lagos, Bottiglieri, Vaschillo & Vaschillo (2012) has suggested the role of HRV 
and biofeedback training in patients whose concussion injury did not resolve in the short 
term, also known as post concussion syndrome (PCS).  The decreased ability for the body 
to regulate HRV on its own post concussion injury as noted by Dewitt and Prough (2003) 
through increased SNS activity could be used to mediate recovery protocols in patients 
with PCS. 
Theses studies are important in that they support the notion that HRV can provide 
information about cardiac dynamics with regard to concussion recovery and return to 
play decisions for athletes.  
2.3.2 Concussion and Audiological Measures  
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The use of audiological measures in the diagnosis and treatment of concussion is 
a very new idea, especially as it pertains to sport related concussion. However, 
audiological measurement has been established for a population of war veterans who 
have suffered mild traumatic brain injuries (mTBI) in the line of duty. The most common 
symptom of neurological dysfunction in veterans is tinnitus, or the persistent ringing of 
ones ears. Lew, Jerger, Guillory & Henry found that in 252 patients suffering mTBIs 
38% reported tinnitus (2007). In a study done by Oleksiak et al. of veterans suffering 
audiological symptoms following an mTBI, of the 21 DPOAEs tested 81% were 
abnormal or absent (2012). The Oleksiak research team went on to recommend OAE 
testing as a way to evaluate sensorineural or subclinical hearing loss (2012). In a case 
study by Cevette and Bielek (1995) investigated the use of TE and DPOAEs, they also 
concluded that OAE measurement added a new dynamic to brain injury assessment. 
Cercanic, Prasher, Raglan, & Luxon tested participants with persistent tinnitus and other 
auditory symptoms following a head injury (1998). They found higher rates of SOAEs 
and reduced suppression in those participants with head injury compared to matched 
healthy controls (Ceranic et al, 1998). Nolle, Todt, Seidl & Ernst noted complete loss of 
the stapedius reflex in almost half of their participants following a head injury (2004).  
When using OAE measurement to evaluate any type of disturbance or injury, it is 
important to note a sex difference. It is well established that SOAEs are more frequent 
and stronger in females and that TEOAEs are stronger in females as well (Bilger, 
Matthies, Hammel & Demorest, 1990; McFadden, 1993, McFadden, 1998; McFadden, 
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Martin, Stagner & Maloney, 2009). There is asymmetry reported in the presence of 
SOAE and TEOAEs where the response is greater in the right ear than the left (Bilger, 
Matthies, Hammel & Demorest, 1990; McFadden et al, 2009). It is also noted that there is 
higher interindividual variability with OAE recordings, DP or TE, but that intra-
individual differences, i.e. left and right symmetry should be very similar (Kemp, 2002).  
 
2.4 Psychological Measures 
2.4.1 Pain Anxiety Symptoms Scale 
The Pain Anxiety Symptoms Scale-20, (PASS-20) (McCracken and Dhingra, 
2002) is a 20-item scale measuring aspects of fear of pain and pain coping. It is the short 
version of the original full length 40-question Pain Anxiety Symptom Scale (PASS) 
developed by McCracken, Zayfert & Gross (1992). The original survey and the short 
version can be broken into 3 response categories cognitive, physiologic and motoric that 
are represented by four subscales; cognitive anxiety, escape/avoidance, fear and 
physiological anxiety (McCracken, Zayfert & Gross, 1992).  The cognitive anxiety 
subscale assess experiences of pain as it manifest in cognitive symptoms i.e. “I feel 
disoriented and confused when I hurt”. The PASS-20 has been shown to highly correlate 
with the cognitive and somatic subscales of the Cognitive Somatic Anxiety Questionnaire 
(CSAQ; McCracken, Zayfert & Gross, 1992). The escape/avoidance subscale assesses 
behavioural responses to pain i.e. “ I try to avoid activities which cause pain”. The 
escape/avoidance subscale has been correlated with the McGill Pain questionnaire and its 
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affective subscale (Burns et al, 2000; McCracken, Zayfert & Gross, 1992) and the Pain 
Behaviour checklist avoidance subscale (McCracken, Gross, Aitken & Carnrike, 1996) 
The fear subscale assesses the fearful response to pain either experienced or anticipated 
i.e. “I dread feeling pain”. This subscale has been correlated to the physiological anxiety 
subscale assessing symptoms relating to somatic arousal i.e. “I become sweaty when in 
pain”. All of the questions in the survey are ranked on a scale from 0 (meaning never) to 
5 (meaning always) (McCracken, Zayfert & Gross, 1992; McCracken & Dhingra, 2002). 
 Clinical and nonclinical patients data can be found in Table 2.1.  
Table 2.1. Data from a clinical and nonclinical population for the PASS-20 
 Abrams, Carleton & 
Asmundson, 2007 
Nonclinical 
McCracken and Dhingra, 2002 
Clinical 
Cognitive 9.0 ±5.2 12.3±6.7 
Escape/Avoidance 6.4±3.8 12.8±6.1 
Fear 4.1±3.7 7.4±6.4 
Physiological 
Anxiety 
4.6±4.0 6.2±5.7 
Total 24.0±13.5 38.6±20.4 
 
For the purpose of this research the main subscale of interest will be physiological 
anxiety as it pertains to physical manifestations of pain such as increased heart rate, 
dizziness and difficulty relaxing (McCracken & Dhingra, 2002). In the initial study to 
construct the PASS-20, it was found to be a suitable alternative for the long form 40 
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question PASS; McCracken & Dhingra concluded that the shortened form is a valid 
alternative for the original (2002).  
2.4.2 Depression Anxiety and Stress Scale 
The Depression Anxiety and Stress Scale (DASS; Lovibond & Lovibond, 1995) is 
a 42-item scale measuring depression, anxiety, and stress symptoms. The DASS exists as 
a public domain survey in two forms, the full length 42 questions versions, and a short 
form 21 question version (DASS-21). Both versions were created by Lovibond & 
Lovibond (1995).  The DASS and DASS-21 are ranked on a scale from 0-3, where 0 
means “did not apply” and 3 means “applied to me very much”. The Depression Scale 
assesses dysphoria, hopelessness, devaluation of life, self-deprecation, lack of 
interest/involvement, and inertia i.e. “I felt downhearted or blue”. The Anxiety Scale 
assesses autonomic arousal, skeletal muscle effects, situational anxiety, and subjective 
experience of anxious affect i.e. “I was aware of dryness in my mouth”. The Stress Scale 
is sensitive to levels of chronic non-specific arousal: it assesses difficulty relaxing, 
nervous arousal, and being easily upset/agitated, over-reactive and impatient i.e. “I felt it 
hard to wind down”(Lovibond & Lovibond, 1995).  Each subscale has 14 questions or 7 
questions for the original and short form respectively. The maximum possible overall 
score is 120 and 61 respectively, indicating higher markers of depression, anxiety, and 
stress with higher scores. The DASS manual includes a scoring section where each scale 
response total is given a ranking from “normal” to “extremely severe”. Normative scores 
for clinical and non-clinical patients have been established and are available in Table 2.2.  
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Table 2.2  
Normative and clinical data for the DASS and DASS-21 
 
Lovibond & 
Lovibond, 1995 
DASS 
Antony et al, 1998 
DASS 
Antony et al, 1998 
DASS-21 
Henry & 
Crawford, 2005 
DASS- DASS-
21 
D
ep
re
ss
io
n 
Normal 0-9 
Mild 10-13 
Moderate 14-20 
Severe 21-27 
Extremely Severe 
28+ 
Nonclinical- 2.2 ±2.8 
Panic Disorder-
12.8±9.5 
OCD-13.4 ±11.5 
Major Depressive 
Disorder- 29.78.4 
Social Phobia-13.2±8.9 
Nonclinical-2.1±3.6 
Panic Disorder-
12.8±10.2 
OCD-13.311.8 
Major Depressive 
Disorder-30.0±9.2 
Social Phobia-13.2±9.3 
DASS- 5.6±7.5 
DASS-21-2.8 
±2.9 
A
nx
ie
ty
 
Normal 0-7 
Mild 8-9 
Moderate 10-14 
Severe 15-19 
Extremely Severe 
20+ 
Nonclinical-1.4±1.9 
Panic Disorder-
16.3±10.0 
OCD-8.86.7 
Major Depressive 
Disorder-12.9±8.7 
Social Phobia- 
11.2±8.9 
Nonclinical-1.2±1.8 
Panic Disorder-
18.710.8 
OCD-9.3±7.6 
Major Depressive 
Disorder-14.0±9.8 
Social Phobia-
12.2±10.2 
DASS- 3.6±5.4 
DASS-21- 
1.9±3.0 
St
re
ss
 
Normal 0-14 
Mild 15-18 
Moderate 19-25 
Severe 26-33 
Extremely Severe 
24+ 
Nonclinical- 4.1± 3.8 
Panic Disorder- 20.3 
±10.8 
OCD- 17.6±10.8 
Major Depressive 
Disorder-25.5± 9.0 
Social Phobia-17.1 
±10.4 
Nonclinical-3.5±3.9 
Panic Disorder-
20.0±11.6 
OCD-17.61±1.0 
Major Depressive 
Disorder-24.3±9.8 
Social Phobia-
16.61±0.9 
DASS- 9.3±8.0 
DASS-21- 
4.7±4.2 
To
ta
l 
Normal 0-78 
Mild 78-87 
Moderate 87-95 
Severe 95-98 
Extremely Severe 
98+ 
  
DASS- 
18.4±18.8 
DASS-21- 
9.4±9.7 
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This scoring model can be used for the DASS-21 by simply multiplying the total 
score in each subscale by 2. In further analysis of the DASS scores, Crawford & Henry 
concluded that the survey is not influenced by gender, occupation, education or age 
(2003).  
The DASS-21 was created primarily for easier clinical use, quicker administration 
and a cleaner factor structure (Antony et al, 1998). It possesses high construct validity 
and reliability and is therefore an accurate representation of the original DASS (Antony 
et al, 1998; Henry & Crawford, 2005). The DASS has shown to correlate with several 
different measures of depression, anxiety and stress. The Beck Depression Inventory 
(BDI) is correlated highly with the depression subscale of the DASS and the DASS-21 
(Antony et al, 1998; Lovibond & Lovibond, 1995), and inversely correlated with positive 
activity portion of the Positive And Negative Affect Schedule (PANAS; Henry & 
Crawford, 2005). The anxiety subscale is highly correlated to the Beck Anxiety Inventory 
(BAI) 
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Chapter 3 
Methodology 
A three-phase approach was used to evaluate CAS TEOAE and HRV. The first 
phase was intended to establish test-retest stability. The second phase evaluated the 
interactions between the baseline testing values of the objective measures of CAS 
TEOAE and HRV with the psychological measure of DASS-21 and PASS-20. The final 
phase evaluated a case study of a concussed varsity athlete at baseline and following 
injury.   
3.1 Ethics Approval 
        The project was approved by the UPEI Research Ethics Board. Each participant 
provided written informed consent to participate. Participants under the age of 18 did not 
complete this project, as additional consent would have been required. 
3.2 Anonymity and Confidentiality 
For the benefit of the participants in this research project an individual 
identification number was used in place of names. Only the research team had access to 
the names and numbers of the individual participants. Where a participant was not a 
UPEI student a seven number ID was generated consisting of year/month/0xx i.e. 
1401001. Once the data were collected and stored in the secure database, each data entry 
was only identifiable by the assigned or generated ID number. Participants all signed a 
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letter of informed consent before participating in the study. The letter of consent can be 
found in Appendix B.  
3.3 Screening 
        All potential participants underwent pre-screening to determine if they were 
eligible to participate in the study.  Pre-screening took place on the first day of testing. If 
the participant passed the pre-screening then they were allowed to continue with the 
remaining portion of the test. Individuals who failed to meet the pre-screening criteria 
were told immediately and were thanked for their interest.   
The pre-screening consisted of each participant completing an Otological 
Normality Questionnaire and a concussion history questionnaire. (Appendix C). The ten-
item Otological Normality Questionnaire was used to ensure that the participant was in 
good auditory health, with no previous ear surgeries or exposure to loud music that would 
negatively affect the test. The concussion history questionnaire was completed after the 
auditory questionnaire. Participants reported their previous medically diagnosed and self-
perceived concussions. Participants in the test-retest reliability study were required to 
have less than 4 concussions in their lifetime and no injury or symptoms within the last 
12 months. Participants in the athlete comparison cohort stage of the study were required 
to be symptom free within the last 6 months for their testing to be considered a baseline 
measures. 
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3.4 Heart Rate Variability 
        Heart rate variability measurements were based on standard resting HRV 
protocols from Berntson et al, 1997. Measurements were taken using the Polar Team2 
Pro heart rate monitoring system (V1.3.04, California). Heart rate monitor straps (Team2 
SoftStrap) were prepared for each participant by moistening the plastic electrodes on the 
reverse side of the strap, and attaching the individual wireless connector (Polar Team2 
transmitter) to the strap. The strap was placed around the chest, directly on the skin, 
below the pectoral muscles approximately below the 10th rib. Once the monitor was 
connected to the tracking system (Polar Team 2 PC software) participants sat in a 
reclining chair that was reclined from 90 degrees to 180 degrees, to place the participants 
were in a supine position. The participants remained in the supine position for 10 
minutes. 
3.4.1 Heart Rate Variability Measurements 
        All HRV measurement was collected using the Polar Team2 pro software and sub 
evaluated using the Kubios (V2.2) University of Eastern Finland heart rate variability 
analysis software. Five minute supine samples of R-R intervals were analyzed using the 
very low artefact correction factor provided by the Kubios software. Seven frequency 
domain variables and three time domain variables were used to assess the different 
measurements that can be derived from HRV assessment. Each measurement and its 
description can be found in Table 3.1. Frequency domain variables represent the outcome 
of the spectral analysis of the R-R intervals within five minute supine sample using a fast 
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Fourier Finite Transform application (Kubios, Finland) and Welch’s periodogram: 256 s 
window with 50% overlap. Time domain methods used standard arithmetic computations 
and were applied directly to the same five-minute resting sample (Tarvainen et al., 2013).  
 
Table 3.1.Description of HRV variables and normative scores based on research.  
V
ar
ia
bl
e 
Definition Task 
Force, 
1996 
Nunan, Sandercock 
& Brodie, 2010 
 
Zhang, 
2007 
 
  
Male Female Age 20+ 
N=63 
LF
 (m
s2 )
 
lo
w
 
fr
eq
ue
nc
y Power in the range of 
0.04-0.15Hz. Indicator 
of sympathetic drive 
1170 
±416 
356 414 346.8 ± 
305.0 
H
F 
(m
s2 )
 
hi
gh
 
fr
eq
ue
nc
y Power in the range of 
0.15-0.4HZ. Indicator or 
Vagal and 
parasympathetic drive 
975 ± 
203 
475 516 216 ± 
300.3 
LF
/H
F 
Ratio of low frequency 
to high frequency 
1.5-2.0 2.3 1.2 2.78 ±2.3 
To
ta
l 
Po
w
er
 
(m
s2  
) 
Variance of all of the 
NN intervals less than 
0.4hZ 
3466 ± 
1018 
  
872 .5 ± 
695.1 
LF
no
rm
 
(n
.u
.) 
Low frequency power 
expressed in normalized 
units LF/(total power-
VLF) x 1000 
54 ± 4 53 46 65.0 
±17.3 
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H
Fn
or
m
 
(n
.u
.) 
High Frequency power 
expressed in normalized 
units HF/(total power-
VLF) x100 
29  ± 3 39 38  34 ±17.4 
R
M
SS
D
 
(m
s)
 
Root mean square of the 
standard deviation of the 
difference between NN 
intervals 
27 ±12 21 19 43.8 ± 
26.8 
pN
N
50
 
The number of pairs of 
adjacent NN intervals 
differing by more than 
50ms (NN50) divided by 
the total number of all 
NN intervals 
- - - -- 
M
ea
n 
H
R
 The average heart rate 
over a 5 minute period 
- - - - 
M
ea
n 
R
-
R
 in
te
rv
al
 
(m
s)
 
The mean of all R-R 
intervals in a five minute 
sample 
-  922 885 761.0 ± 
132.3 
 
 
3.4.2 Heart Rate Variability Data Analysis 
 For spectral analysis of HRV, R-R intervals from the five-minute resting sample 
were exported from Polar to Kubios Heart Rate variability Software (V 2.2) in beat-to-
beat format. Samples were subjected to the very low-level artefact correction, to reduce 
noise and errors from the Polar sample. A five-minute resting sample was selected for 
analysis. Selection of the sample was at the researcher's discretion, but started 3 minutes 
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into the recording to ensure that the participants were at true resting HRV and lasted 5 
minutes in total. 
3.5  Contralateral Auditory Suppression of Transient Evoked Oto-Acoustic 
Emissions 
Assessing CAS TEOAE requires a multi-step process. Participants are first 
required to complete the Ontological Normality Questionnaire and an otoscopy to ensure 
there were no abnormalities in the ear and ear canal prior to testing.  Complete CAS 
TEOAE testing was carried out using the test paradigm and protocol of Otodynamics ILO 
292 V6 otoacoustic emission analyzer (London, UK). The first step measured the 
transient evoked otoacoustic emission (TEOAE) in each ear, for each participant. This 
test was performed in the right and left ear. UGD TE+DPOAE probes (Otodynamics 
Audiology Systems, A80-16-10) were fitted into the participant’s ears at the beginning of 
testing, and remained in place until testing was completed. The TEOAE was measured in 
the test ear at a peak equivalent sound pressure (pe SPL) of 80 dB. A click presentation 
rate using 50 clicks per second using a linear technique (continuously). After TEOAE 
was measured and the response demonstrated a parameter estimate of >70% stability and 
reproducibility, the participant moved onto the spontaneous OAE (SOAE) test. The 
SOAE has no direct clinical application, but it is important in interpreting TEOAE and 
CAS TEOAE (Killan, Lutman, Thyer & Montelpare, 2012). The SOAE was measured in 
a manner known as synchronized SOAE (SSOAE) that are long lasting oscillations 
(Bright, 2002) again in right and left at 80 dB pe SPL in a non-linear, spontaneous 
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method at 50 licks per second.  The presence of SOAEs was recorded if the response had 
amplitude greater than -25 dB SPL (Killan, Lutman, Thyer & Montelpare, 2012). The 
final step in CAS TEOAE testing was the estimate of contralateral auditory suppression. 
 This method of testing operates two separate OAE recordings, one when a suppressor is 
present in the opposite (contralateral) ear and one without the suppressor present 
(ipsilateral) ear. The recording of the two tests is switched every three seconds to 
minimize the effect of changes in the ear. For this test the TEOAE level was set at 60 dB 
pe SPL linear click, and the suppressor or masker level is set at 65 dB pe SPL broadband 
noise (BBN) consistent with the test parameters recommended by Hood et al. (1995) to 
maximize the suppressive effect, while not evoking the auditory reflex and giving false 
results. Quantification of suppression was estimated using a customized computer code 
and can be found at: http://health.ahs.upei.ca/concussion/CASfrm3.php. (Montelpare, 
2014).  One main problem with testing contralateral suppression, in that when switched 
from assessing the right ear to the left ear, there is no way to ensure that the probe is 
getting an adequate signal for broadband noise. This problem was mediated by doing a 
check fit for both left and right ear at the beginning of the assessment, and instead of 
switching the probes in the participant's ears, the probe sockets were switched in the 
device. All data were stored on a secure server at UPEI. All parameters for the 
suppression test can be found in Figure 3.1. Total test time for all of the steps was 
approximately 12 minutes.  All otological testing was carried out in conjunction with 
HRV analysis and therefore measured while the participant was in the supine position
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.  
Figure 3.1 Parameters for the test set up for CAS TEOAE using the Otodynamics 
Audiology system 
3.5.1 CAS TEOAE Measurements 
CAS TEOAE was measured using four different variables and two different 
frequencies of measurement. The frequencies of 1414Hz and 2000Hz were chosen as 
they demonstrated the highest confidence levels and were supported by the literature in 
having consistently the highest confidence levels and best suppression values. 
Description of the four variables can be found in Table 3.2 below. The scores for the right 
(x) and left (y) ipsilateral ears for suppression were determined by calculating the 
difference between the TEOAE click at 60 dB and the BBN at 60 dB assessed in the 
ipsilateral ear. Sum scores were calculated by adding the measurement values recorded 
for the right and left ears and the difference scores (Diff) were calculated by subtracting 
the measurement values for the right and left ears.  Thus the suppression score for the 
right ear at 1414Hz is X1414 and so on.  
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3.6 Depression, Anxiety and Stress Scale (DASS-21) 
        The DASS-21 (Lovibond & Lovibond, 1995) was administered as an online 
survey. The 21-item survey was administered with a drop down menu after each question 
with the four response options. Once the survey was completed it was submitted to an 
online database along with a unique ID number for each participant. The survey can be 
analyzed as a whole or it can be broken down into three different subscales, depression, 
anxiety and stress. Each subscale has 7 specific questions. The complete survey can be 
found in Appendix D 
3.7 Pain Anxiety Symptom Scale (PASS-20) 
The PASS-20 (McCracken and Dhingra, 2002) was also administered online.. The 
20-item survey was scored using a 5-point ordinal scale with responses ranging from 0-5 
with 0 meaning “never” and 5 meaning “always”. Once the survey was completed the 
data were stored in a secure database. Information could only be identified by an assigned 
ID number that was only available to the research team. The complete survey can be 
found in Appendix E. 
Table 3.2 Description of the variables for CAS TEOAE 
R (dB) The difference in dB of the sums of sounds recorded in the ipsilateral (right) l 
ear when just the click stimulus is present, and then the contralateral white 
broadband noise is present. (On 3 seconds, off 3 seconds) 
L (dB) The difference in dB of the sums of sounds recorded in the ipsilateral (left) 
ear when just the click stimulus is present, and then the contralateral white 
broadband noise is present. (On 3 seconds, off 3 seconds) 
Sum =R+L (dB) Sum of the suppression values in the right and left ear, i.e. total suppression 
Diff = 𝑹 − 𝑳  (dB) Absolute value of the difference in suppression of the right and left ear.  
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3.8 Phase one- Test Retest Stability 
 Phase one of this study used a test-retest design study was to evaluate the stability 
of HRV and of CAS TEOAE in a healthy young adult population (n=25). The complete 
demographic information for these participants can be found in Table 3.3. Participants 
were recruited via word of mouth and social media recruitment.  Participants were asked 
to come to two different testing sessions, separated by a two-week period. Before each 
session they were asked not to wear headphones with music, to have clean ears and 
abstain from coffee or energy drinks for 12 hours prior to testing. Once participants were 
cleared through the pre-screening protocol (as described above) they underwent testing 
for both HRV and CAS TEOAE simultaneously. 
3.8.1 Statistical Analysis 
Data the first phase test-retest reliability was analyzed using a nonparametric 
statistical analysis technique, because the HRV data were nonparametric. CAS TEOAE 
was analyzed in the same manner for consistency in the analysis. The McNemar Chi-
Square Statistic (1) and the Kappa z-score of agreement (2) were used to establish the test 
retest reliability of HRV and CAS TEOAE. The data were analyzed using a custom 
design webulator located at: http://health.ahs.upei.ca/webulators/mcnkap2.php and the 
code for this webulator is in Appendix F. (Montelpare & McPherson, 2000). Coefficient 
of variation and a paired t-test were also calculated to assess variation in the sample to 
account for the CAS TEOAE data being parametric. 
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(1). McNemar= ( !!! !!)!(!!!)   
(2) Kappa 1.Compute row percentages  
row 1= p1.=(a+b)/N 
row 2= p2.=(c+d)/N 
column 1= p.1=(a+c)/N 
column 2= p.2.=(b+d)/N 
2. Compute pi terms 
Oobs=(Cell a)+(Cell d ) 
Oexp= (p1.*p.1) +(p2.*p.2) 
3. Compute Kappa 
Kappa= (!!"#!!"!")(!!!"#$)  
 (3) Coefficient of Variation=Standard Deviation /Mean 
 
 
 
 
 
 
 
 
Table 3.3. Demographics of participants for Phase 1 and Phase 2 
 Phase 1 Phase 2  
Participants (n) 25 75 
Male (n) 9 23 
Female (n) 16 52 
Height (cm) 171.6 ± 7.3 168.6 ± 9.6 
Weight (kg) 71.2 ±2.9 152.6 ± 25.2 
Previous concussion 0 23 
Sport - Basketball- 7 
Hockey-18 
 Soccer- 29 
 Rugby- 8 
 Swimming- 4  
Field Hockey- 9 
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A paired t test was also used to evaluate the statistically difference between day one and 
day two. The webulator used for that assessment can be found at: 
http://health.ahs.upei.ca/webulators/t2smplpool2.php (Montelpare, 2015) 
3.9 Phase Two- Athlete Baseline Testing  
          A convenience sample of UPEI varsity athletes (n=75) from six different sports: 
(i) soccer, (ii) rugby, (iii) field hockey, (iv) basketball, (v) hockey and (vi) swimming, 
were asked to participate in baseline screening. Participants were recruited via a third 
party email, and registered for appointments. Descriptive participant statistics for this 
cohort can be found in Table 3.1.  During various pre-season training camps in 
September 2014 athletes were asked to complete the DASS-21 and PASS-20, as well as 
an online consent form prior to arriving the clinic for testing.  Once the surveys were 
completed, participants scheduled appointments at the UPEI Concussion Evaluation 
Clinic. At the clinic, participants were evaluated on the CAS TEOAE and HRV 
simultaneously (as above). Testing was done simultaneously for the sake of time, as 
participants were doing other neurocognitive and concussion screening tests during this 
appointment.   
3.9.1 Statistical Analysis 
Univariate statistics were used to demonstrate the overall measures of central 
tendency and variance for the measures selected in this cohort. A set of measurements 
was selected for each of the objective tests. For example, while HRV used 11 
measurements, the following five were used to represents the entire set of measurements: 
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(i) LF, (ii) HF, (iii) LF/HF, (iv) RMSSD and (v) mean HR. Similar to the establishment 
of a representative sample in HRV testing, the CAS TEOAE included 8 measurements.  
These measurements were selected as they showed the highest stability in phase one, 
were not a redundant measurement, were consistently used in the literature and were the 
most consistent in the athletes baseline testing. A total of 4 measures were selected from 
the original set to represent all measurement of the CAS procedure :(i) Y1414, (ii) 
Sum1414, (iii) X2000, (iv) Diff2000. Theses measurements were selected as they showed 
the highest confidence levels in the athlete baseline testing and evaluated all four of the 
different aspects of CAS TEOAE. 
Further, because the participants were drawn from the larger sample of varsity 
athletes enrolled at UPEI, tests for homogeneity of variance using the coefficient of 
variation was used to enable the researcher to quantify the variance within each sample. 
A univariate multiple regression approach was used to quantify relationships between the 
measures for the DASS-21 and the PASS-20 independently with the following set of 
predictor variables: CAS TEOAE, demographics, activity type, and concussion history in 
one stage. The measures for the DASS and the PASS were analyzed independently with 
measures of HRV, demographics, activity type, and concussion history in a second stage. 
The relationship between CAS TEOAE and HRV with the subscales of the 
DASS-21 and PASS-20 were evaluated using the Spearman Correlation Coefficient 
tested the relationships with CAS TEOAE and HRV and the subscales. The DASS-21 
and PASS-20 subscales were created by separating the responses of the DASS-21 and 
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PASS-20 independently, into two groups: individuals that scored above the fiftieth 
percentile and individuals who scored below the fiftieth percentile on the psychological 
scales. Next, the Spearman Correlation Coefficient test was used to assess the two groups 
independently for the DASS-21 and PASS-20 subscales, as well as to determine if there 
was a significant relationship between the selected measures of the HRV test and the 
CAS TEOAE test. Finally, logistic regression analysis was used to evaluate the 
relationship between the DASS-21 and PASS-20, independently by concussion history 
for the given measurements of HRV and the CAS TEOAE test. The SAS program that 
was used for the Spearman Correlation Coefficient and Logistic Regression can be found 
in Appendix G  
3.10 Phase Three- Case Study 
Throughout the testing period varsity athletes were told to present themselves to 
the clinic if they suffered a concussion or presented with concussion symptoms at any 
time during the season.  It was observed that during the 2014-2015 season, four varsity 
athletes contacted the Concussion Evaluation Clinic with injuries related to participation 
in sporting events. Of the four athletes reporting concussion, two had completed the 
baseline testing completely, and one consented to have the post-injury evaluation 
completed. This latter participant presented to the clinic two days post injury, and 
completed four assessments of HRV and CAS TEOAE. Data from the Sum1414 variable 
in CAS TEOAE and the LF/HF ratio in HRV are presented here to demonstrate the 
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dynamics of the recovery process with regard to the original injury recovery process 
curve presented in Appendix A. 
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Chapter 4 
Results 
4.1 Phase One Results 
The mean scores and standard deviations were calculated for all eleven variables of HRV 
and eight variables of CAS TEOAE. Table 4.1 shows all HRV variables and Table 4.2 
shows all CAS TEOAE variables and a two-tailed t-test. As a first test of stability, the 
pair wise t-test was computed for each of the variables in both HRV and CAS TEOAE 
measures independently. Based on the decision rule of - tcritical-2.06 p≥0.05, degrees of 
freedom=24 no significant difference was observed between measures on day one versus 
measures on day two. 
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Table 4.1.Mean scores ± standard deviation and t-test value for the test retest reliability 
for all HRV measurements (n=25). 
 
Day 1 Day 2 t-test 
LF (ms2) 2534.81 ± 2078.7 1706.38  ± 1514.3 1.61 
HF (ms2) 3932.52 ± 4412.0 3806.97  ± 3805.2 0.11 
LF/HF 1.18 ± 0.97 0.838  ± 0.44 1.36 
Total Power 8057.20 ± 6969.80 8337.88  ± 7332.90 -0.14 
RMSSD 87.4 ± 74.3 69.15  ± 36.1 1.10 
pNN50 (%) 39.91 ± 25.20 36.93  ± 24.8 0.42 
Heart Rate (bpm) 66.83 ± 9.41 66.21 ± 8.93 0.23 
RR (ms) 926.43 ± 139.76 919.62  ± 126.87 0.18 
SDNN (ms) 93.50 ± 57.76 88.14  ± 41.26 0.38 
LF norm (n.u.) 42.80 ± 20.10 38.38 ± 20.92 0.76 
HF norm (n.u.) 55.40 ± 20.34 59.36  ± 24.03 -0.64 
df=24, p<0.05, tcritical-2.06 
decision rule: tobserved > tcritical  then reject H0 x1≠x2 
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Table 4.2.Mean scores ± standard deviation and t-test value for the test retest reliability 
for all CAS TEOAE measurements (n=25). 
 
Day 1 Day 2 t-test 
X1414 1.07 ± 1.96 0.52 ± 2.5 1.10 
Y1414 1.08 ± 2.53 1.58 ± 1.58 -0.84 
Sum1414 2.11 ± 3.39 2.12 ± 2.98 -0.01 
Diff1414 1.98 ± 2.18 1.99 ± 2.15 -0.02 
X2000 1.03 ± 1.33 0.79 ± 0.82 0.76 
Y2000 0.64 ± 1.78 0.6 ± 0.96 0.10 
Sum2000 1.60 ± 2.18 1.28 ± 1.4 0.62 
Diff2000 1.32 ± 1.63 0.56 ± 0.96 2.01 
df=24, p<0.05, tcritical-2.06 
decision rule: tobserved > tcritical  then reject H0 x1≠x2 
 
The next step in measuring the stability and the agreement between the objective 
measures of HRV and CAS TEOAE between test days was to use the McNemar test of 
symmetry, and the Kappa statistic for agreement. To calculate the McNemar test of 
symmetry a binary scale was used based on the median score for each variable on each 
test day. Each data point was assessed on the binary scale where 0 indicated a score 
below the median and 1 indicated a score above the median. Using the McNemar Chi 
Square, data points were assigned to a cell in a two by two table based on whether the 
individual scored the same on the binary scale for day one and day two. Figure 4.1 
presents the structure of the McNemar Chi Square test to determine the probability that 
an individual will score the same on day one and day two.  
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 Test day 1  
 
Test Day 2  
 1 0 
1 A B 
0 C D 
Figure 4.1. Diagram of the McNemar Chi Square 
 
The results indicate that there were no significant differences between day one 
and day two for any of the variables of the objective measures of HRV and of CAS 
TEOAE. Table 4.3 shows the McNemar scores for HRV, and Table 4.4 shows the 
McNemar scores for CAS TEOAE.  
Given that the variables were not statistically different between test days for the 
objective measure of HRV and CAS TEOAE, the Kappa statistic of agreement was used 
to assess whether there was significant agreement between the two test days. The Kappa 
statistic also uses the Chi Square, Figure 4.1, but assesses if the variables differ 
significantly from what is expected by chance. The zKappa is shown to be significant if the 
kappa score is significantly different from zero and is falling outside the region of 
acceptance (-1.96≤ x ≥1.96). We can conclude that there is significant agreement between 
day one and day two. Three variables showed significant agreement for the objective 
measures of HRV and CAS TEOAE: RMSSD (z=2.22) and Mean HR (z=2.65), and 
Sum1414 (z=2.2) 
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Table 4.3.Test retest data for interclass correlation, McNemar statistic and Kappa z score 
for HRV measurements. 
 
McNemar 95% CI Kappa Kappa Score zkappa 
LF/HF -0.3 0.018-0.225 0.124* 0.61 
LF 0.3 0.009-0.222 0.582* 0.12 
HF 0.63 0.104-0.283 0.981* 0.19 
RMSSD 0.38 0.362-0.52 0.441* 2.22* 
HR -0.822 0.431-0.631 0.522* 2.65* 
Total Power 1.26 0.139-0.299 0.219 1.15 
PNN50 -0.3 0.017-0.266 0.121 0.61 
RR -0.71 0.29-0.44 0.363 1.84 
SDNN 0 0.11-0.29 0.2 0.99 
LF n.u. 0 0.28-0.43 0.351 1.75 
HF n.u. -0.3 0.017-0.23 0.121 0.61 
* denotes a significant result	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Table 4.4.Test retest data for the McNemar statistic and Kappa z score for CAS TEOAE 
measurements. 
 
McNemar 95%CI Kappa Kappa Score Zkappa 
X 1414 0.24 0--0.117 -0.357 -­‐1.79 
Y1414 0.33 0.199-0.354 0.277* 1.39 
Sum1414 -0.38 0.359-0.516 0.437* 2.2* 
Diff1414 -0.58 0-0.167 0.045 0.23 
X2000 -0.71 0.282-0.482 0.3548* 1.8 
Y2000 -1.81 0--0.025 -0.229 -­‐1.4 
Sum2000 1.6 0-0.06 -0.206 -­‐1.21 
Diff200 -1.67 0.235-0.372 0.303* 1.65 
Dsjk; 
* denotes a significant result 
 
4.2 Phase Two Results 
The mean scores for the objective measures of HRV and CAS TOAE in a sample 
of 75 athletes were compared to the Day 1 mean scores for the cohort of individuals used 
in establishing the stability of the HRV and CAS TEOAE tests. The mean scores for all 
variables of the objective measures of HRV and CAS TEOAE were not statistically 
different based on the confidence interval comparison where tcritical-1.99 p-value≤0.05 and 
degrees of freedom= 98.  
Since the variables were not statistically different from the test retest population, 
the range of variation in scores for the 75 athletes was tested for variability using the 
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coefficient of variation. Table 4.5 shows the variables used for phase 2, their mean 
scores, coefficient of variation and t-test values for HRV and Table 4.6 shows the 
variables for CAS TEOAE their mean scores, coefficient of variation and t-test values.  
 
Table 4.6.The mean scores, coefficient of variation and pair t-test values for variables of 
CAS TOAE for n=75 varsity athletes. 
 
Mean StD CV t-test 
Y1414 1.06 1.98 1.87 -0.036 
Sum1414 2.52 4.21 1.67 0.49 
X2000 1.09 1.61 1.47 -1.08 
Diff200 1.43 2.24 1.54 0.27 
df=98, p<0.05, tcritical-1.99 
decision rule: tobserved > tcritical  then reject H0 x1≠x2 
 
Table 4.5.The mean scores, coefficient of variation and pair t-test values for variables of 
HRV for n=75 varsity athletes. 
 
Mean StD CV t-test 
LF 4278.94 15014.56 3.51 0.98 
HF 4648.63 7565.97 1.63 0.58 
LF/HF 0.82 0.62 0.76 -1.74 
RMSSD 102.83 71.35 0.69 0.91 
HR 64.19 9.74 0.15 -1.19 
df=98, p<0.05, tcritical-1.99 
decision rule: tobserved > tcritical  then reject H0 x1≠x2 
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The baseline scores of the subscales of the DASS-21 (Table 4.7) and PASS-20 
(Table 4.8) were assessed for significant relationships between the selected variables of 
the objective measures of HRV and CAS TEOAE.  
 
Table 4.7.Mean scores for the DASS-21 subscales at baseline testing of 75 UPEI varsity 
athletes 
DASS-21 Mean StD 
Depression 1.44 2.73 
Anxiety 2.51 2.87 
Stress 2.59 3.29 
 
Table 4.8.Mean scores for the PASS-20 subscales at 
baseline testing of 75 UPEI varsity athletes 
PASS-20 subscales Mean StD 
Escape 5.67 4.02 
Fear 3.83 3.94 
Cognitive 8.04 4.7 
   Physiological 3.03 3.59 
  
Given that there were no significant correlations between the subscales of the 
DASS-21 or the PASS-20 with the objective measures of HRV and CAS TEOAE, the 
next step was to create binary groups for the subscale scores of the DASS-21 and the 
PASS-20. In this process, each individual subscale score was separated into two groups 
  
 
63 
by splitting the scale at the median score. Table 4.9 reports the subscale median scores 
and the subsequent number of individuals in each binary group.  
 
The DASS-21 and PASS-20 subscale group scores were used as the dependent 
variables, first in Spearman correlations with the objective measures of HRV and of CAS 
TEOAE, and second as dependent measures in logistic regression models intended to 
determine the influence of objective measures of HRV and of CAS TEOAE on subscale 
reports of the DASS-21 and PASS-20.  
The results indicated that there was a significant relationship found in the 
escape/avoidance group of the subscale of the PASS-20 and the LF/HF ratio 
measurement of HRV (p< 0.05, rsp=-0.25). There were no other significant relationships 
Table 4.9.Distribution of number of participants based on responders and non-
responders for the subscales of the DASS-21 and PASS-20, where group 0 is non-
responders, and group 1 is responders. 
 
Group	  0 Group	  1 
Anxiety	  Group Median	  =	  2 n=33 n=42 
	  Depression	  Group Median=	  0 n=43 n=32 
Stress	  Group Median=	  1 n=28 n=47 
Fear	  Group Median=	  5 n=34 n=41 
Cognitive	  Group Median	  =	  7 n=32 n=43 
Escape	  Group Median	  =5 n=41 n=34 
	  Physiological	  Group	  Median	  =	  2 n=44 n=31 
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found between the other subscales of the PASS-20 and the subscales of the DASS-21 and 
the objective measures of HRV. Similarly there were no significant pairwise correlations 
observed between the subscale group scores for the DASS-21 and PASS-20 with the 
objective measures of CAS TEOAE.  
In the next phase of statistical analysis, logistic regression was used to determine 
the influence of the objective measures of HRV and of CAS TEOAE on the independent 
subscale groups of the DASS-21 and PASS-20. The results indicate that the 
escape/avoidance subscale group was predicted by LF/HF and mean heart rate (Table 
4.10), the cognitive group was predicted by LF/HF and mean heart rate (Table 4.11), the 
stress group was predicted by mean heart rate and RMSSD (Table 4.12), the fear group 
was predicted by LF/HF and mean heart rate (Table 4.13), the anxiety group was 
predicted by mean heart rate and RMSSD (table 4.14) and the physiological group was 
predicted by LF/HF (Table 4.15). 
Table 4.10.Analysis of Maximum Likelihood Estimates (dependent variable= Escape 
Group; r square= 0.18) 
Predictor Variables Parameter Estimate Standard Error Wald Chi-
Square 
p value 
LF/HF -1.35 0.55 6.002 0.014 
Mean HR 0.021 0.010 4.16 0.041 
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Table 4.11.Analysis of Maximum Likelihood Estimates (dependent variable= Cognitive 
Group; r square= 0.106) 
Predictor Variables Parameter Estimate Standard Error Wald Chi-
Square 
p value 
LF/HF -0.84 0.47 3.19 0.074 
Mean HR -0.019 -0.010 3.62 0.057 
 
Table 4.12.Analysis of Maximum Likelihood Estimates (dependent variable= Stress 
Group; r square=0.13) 
Predictor Variables Parameter Estimate Standard Error Wald Chi-
Square 
p value  
Mean HR 0.026 0.011 6.14 0.013 
RMSSD -0.011 0.0063 3.22 0.073 
 
Table 4.13.Analysis of Maximum Likelihood Estimates (dependent variable= Fear 
Group; r square= 0.091) 
Predictor Variables Parameter Estimate Standard Error Wald Chi-
Square 
p value  
LF/HF -0.88 0.47 3.57 0.059 
Mean HR 0.02 0.0099 3.98 0.046 
Table 4.14.Analysis of Maximum Likelihood Estimates (dependent variable= Anxiety 
Group; r square= 0.12) 
Predictor Variables Parameter Estimate Standard Error Wald Chi-
Square 
p value 
Mean HR 0.022 0.011 4.12 0.032 
RMSSD -0.014 0.0070 3.87 0.049 
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Table 4.15.Analysis of Maximum Likelihood Estimates (dependent variable= 
Physiological Group; r square= 0.12) 
Predictor Variables Parameter Estimate Standard Error Wald Chi-
Square 
p value  
LF/HF -1.03 0.58 3.18 0.075 
 
 
As a result of identifying these significant objective predictors of the anxiety 
subscale group of the DASS-21 and the fear subscale group, cognitive subscale group and 
escape/avoidance subscale group of the PASS-20 a subsequent logistic regression 
analysis was used to determine if these relationships were present when the data were 
separated according to concussion history. Table 4.16 shows the distribution of 
participants based on concussion history and gender. However, the data were not 
separated by gender in subsequent analyses because of the smaller cell size. 
Table 4.16. Distribution of participants by sex and presence of concussion history for a 
sample of n=75 varsity athletes. 
 
Male Female 
No concussion history 17 31 
Yes concussion history 6 21 
The results indicated that in the sub classification of individuals with no previous 
concussion history demonstrated the same findings as the total group.  That is, the 
escape/avoidance group was predicted by LF/HF and mean heart rate (Table 4.17), stress 
group was predicted by mean heart rate (Table 4.19), fear group was predicted by LF/HF 
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and mean heart rate (Table 4.20) and anxiety group was predicted by mean heart rate and 
RMSSD (Table 4.20). However, the similarities in relationships were not present in the 
group that reported a previous concussion. The depression group was predicted by mean 
heart rate (Table 4.18), which was not present in the total group, or the group with no 
previous concussion. In particular where the LF/HF ratio was a significant predictor of 
the escape/avoidance subscale group in the concussed group, this significant finding was 
not observed in the group of individuals that had reported a previous history of 
concussion.  
 
Table 4.17.Analysis of Maximum Likelihood Estimates for no previous concussion 
history (dependent variable= Escape Group r square= 0.26) 
Predictor Variables Parameter Estimate Standard Error Wald Chi-
Square 
p value 
LF/HF -1.79 0.80 4.96 0.026 
Mean HR -0.039 0.015 6.81 0.0090 
Table 4.18.Analysis of Maximum Likelihood Estimates for yes to previous concussion 
history (dependent variable= Depression Group r square= 0.17) 
Predictor Variables Parameter Estimate Standard Error Wald Chi-
Square 
p value 
Mean HR -0.043 0.026 2.78 0.095 
 
Table 4.19.Analysis of Maximum Likelihood Estimates for no previous concussion 
history (dependent variable= Stress Group r square= 0.17) 
Predictor Variables Parameter Estimate Standard Error Wald Chi-
Square 
p value 
Mean HR 0.026 0.013 4.35 0.037 
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Table 4.20.Analysis of Maximum Likelihood Estimates for no previous concussion 
history (dependent variable= Fear Group r square= 0.20) 
Predictor Variables Parameter Estimate Standard Error Wald Chi-
Square 
p value 
LF/HF -1.60 0.81 3.91 0.048 
Mean HR 0.028 0.014 4.12 0.043 
 
 
Table 4.21.Analysis of Maximum Likelihood Estimates for no previous concussion 
history (dependent variable= Anxiety Group r square= 0.25) 
Predictor Variables Parameter Estimate Standard Error Wald Chi-
Square 
p value 
Mean HR 0.035 0.014 5.99 0.014 
RMSSD -0.017 0.0093 3.25 0.071 
 
 
 
 In summary it was found that selected variables for the measurement of HRV and 
CAS TEOAE were stable between testing day 1 and day 2. There were no significant 
relationships between the object measures of HRV and CAS TEOAE with the 
psychological measures of DASS-21 and PASS-20. However, when the DASS-21 and 
PASS-20 subscales were broken down into two distinct groups of responders and non-
responders and significant relationship was found with the escape/avoidance subscales of 
the PASS-20 and the LF/HF ratio.  Upeon further breakdown of the group scores based 
on history of previous concussion, it was found that the group with no history of pervious 
concussion exhibited the same relationships with the DASS-21 and PASS-20 subscales as 
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the total population, but the group with a previous concussion history did not show those 
relationships, in fact they displayed the complete opposite relationships.  
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Chapter 5 
Case Study 
One varsity athlete presented to the Concussion Evaluation Clinic in January 2015 
with a physician-diagnosed concussion. This participant had completed the full baseline 
profile in September 2014.  During baseline testing the participant reported no previous 
history of concussion, and no general concussion symptoms based on the SCAT 3 
symptom reporting section. The participant presented at the clinic 48 hours post injury, 
where the circumstances of the injury were recorded, symptoms were reported based on 
the SCATIII and the participant was assessed on the objective measures of HRV and 
CAS TEOAE. Following the injury, the participant was assessed four times: 1) 48 hours 
post injury, 2) 4 days post injury, 3) 7 days post injury and 4) 10 days post injury. The 
results of the athlete’s symptom reporting (Figure 5.1) showed a decline over the course 
of the four days of testing, which is consistent with an expected recovery pattern.  
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For the objective measure of HRV and CAS TEOAE, one variable for each 
measurement was selected to assess the changes post injury and the subsequent recovery 
to baseline. The LF/HF ratio was selected as the objective measure of HRV, because it is 
an indicator of the sympathovagal balance and showed good stability in measures of test-
retest reliability. The sum1414 measurement was selected as the objective measure to 
represent the CAS TEOAE test as it had the highest confidence interval over the four 
testing days for the participant and showed good stability in the measures of test-retest 
reliability.  The post injury scores were again plotted with the baseline estimate to show 
the recovery of the athlete following injury. Figure 5.2 and Figure 5.3 show the two 
variables selected at baseline and the four days following injury for the objective 
measures of HRV and CAS TEOAE.  
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Figure 5.1 The baseline and post injury values for reported 
symptoms based on the symtpom reporting scale from the 
SCAT 3 
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Figure 5.2 The baseline and post injury scores for sum1414 of 
the objective measure of CAS TEOAE for a concussed 
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Figure 5.3 The baseline and post injury values for the LF/HF 
variable of the objective measure of HRV for a concussed 
individual  
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These figures were compared to the injury recovery hypothesis (Appendix A) to 
assess the return to a “healthy” baseline value. The participant demonstrated a 49% drop 
in the value of LF/HF and a 29% drop in the value of sum1414 post injury shown in 
Table 5.1. This drop in score indicates a change in HRV and decrease in suppression 
values for CAS TEOAE, followed by a steady increase towards the baseline value for 
each variable.  
 
Table 5.1. Percentage change in the variables LF/HF and Sum1414 for the objective 
measures of HRV and CAS TEOAE following a concussion, compared to baseline 
values.  
 
 Baseline Day 1 Day 2 Day 3 Day 4 
R
T
P 
Sum1414  100% 49% 38% 9% 49% 
LF/HF 100% 29% 18% 40% 40% 
RTP: denotes return to play without subsequent follow-up 
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Chapter 6 
Discussion 
The primary purpose of this thesis was to assess the stability of HRV and CAS 
TEOAE as objective measures of concussion baseline assessments and return to play 
criteria. The results from phase one of the study, to determine measures of stability 
showed that the selected tests were stable from day one to day fourteen. Consistent with 
the findings from Fagard, Pardaens & Staessen (1999) there was large interindividual 
variability in the short term (measurement five minute sample) of HRV as indicated by 
large standard deviations between subjects. The large inter subject variability that was 
expected because of the observed physical variability across athlete groups. In this study 
athletes were homogenous, in that they were all identified as varsity level athletes, 
however the population consisted of athletes from six different sports, some of which are 
based on contact and other based on speed and agility, it was not surprising to observe 
high variability in this physiological measure given the physiological/ physical demands 
of the athletes in their respective sports. The large inter subject variance was an important 
consideration when using HRV as an indicator of physiological consequences of 
concussion. In other words, it was impossible to establish a definite starting point 
quantitatively to represent all athletes within the cohort. As a result, the nonparametric 
McNemar chi-square was used to provide an estimate of the stability of individuals on the 
selected measures on day one to day two. Likewise the Kappa statistic proved to be a 
valuable indicator of the measures of agreement between test measurements on each of 
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the evaluation days. The results of this process enable us to suggest that the specific 
measures from HRV (LF/HF and RMSSD) and the specific measures of CAS TEOAE 
(Sum1414 and Diff2000) may be considered as a stable and useful estimator of the 
physical consequence of a concussion. That is to suggest that these measures provide 
reliable estimates of baseline measures for two essential cranial nerve functions in an 
athlete population. Another important finding of this phase has been to build on the 
repeatability study of OAEs by Mishra & Lutman.  Using a very comprehensive 
statistical analysis and perfect clinical settings Mishra and Lutman concluded that in 
normal hearing individuals the inhibition from contralateral suppression ranged from 0.96 
dB to 1.47dB, which are similar to the mean scores calculated in phase one (2013). It is 
also important to note that phase one demonstrated the stability of CAS TEOAE in a non-
clinical, less controlled setting than that of Mishra & Lutman, and therefore CAS TEAOE 
can be repeated in less than ideal settings and obtain similar results.  
The secondary purpose of this thesis was to establish relationships with the 
psychological measures of DASS-21 and PASS-20 for the objective measures of HRV 
and CAS TEOAE by determining the relationships between the objective measures of 
HRV and CAS TEOAE with the psychological subscales of the DASS-21 and the PASS-
20. Consistent with our expectation that since the measures of CAS TEOAE should 
function independently of emotional drive or underlying psychological events, CAS 
TEOAE variables did not correlate strongly with the psychologically based scale 
estimates of DASS-21 and PASS-20, as determined with a non-parametric Spearman 
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Correlation test. The DASS-21 and PASS-20 subscales - when computed as binary 
scores- provide estimates of an individual’s emotional state in relation to depression and 
anxiety, and therefore should not be directly influenced by the physical disruption of a 
concussion injury. 
Conversely, since heart rate is functionally influenced by emotional state through 
sympathovagal control (Appelhans & Luecken, 2006; Appelhans & Leucken, 2008) it 
was expected that the DASS-21 and PASS-20 subscales- when computed as binary 
scores- would correlate with measures of HRV. This expectation suggests that the 
activity of the vagal nerve can be quantitatively related to the scoring of emotional state. 
While this relationship was not observed in a simple pairwise correlation, based on the 
Spearman non-parametric correlation test, it was observed in a more sophisticated 
modeling approach based on logistic regression. In the development of the logistic 
regression model, the subscale of PASS-21- escape/avoidance (defined as an individual's 
drive to avoid situations which are perceived to cause pain) (McCracken & Dhingra, 
2002) when scored as a binary variable was negatively associated with the LF/HF ratio 
measure of HRV. This relationship is described as follows: when an individual scored 
low on escape/avoidance, below the median score the LF/HF ratio score was high. A low 
score on escape/avoidance is expected under normal conditions, as is the predominance 
of sympathetic modulation of heart rate. Conversely a high score on escape/avoidance 
under normal conditions requires a predominance of parasympathetic modulation to 
  
 
77 
control the sympathetic drive of fight or flight, which translates to a low score on the 
LF/HF ratio (Figure 6.1). 
The LF/HF ratio, mean heart rate and RMSSD were the HRV variables that 
consistently showed relationships to the psychological measure of DASS-21 and PASS-
21. It is important to note that these variables were all highly correlated with one another 
using the Spearman Correlation Coefficient for the varsity athlete population. 
 
 
Figure 6.1 Description of the relationship of the escape/avoidance with the LF/HF 
ratio of HRV.  
 
While this complex relationship was observed in the non-concussed cohort, no 
relationship between measures of HRV and DASS-21 or PASS-20 were observed in 
logistic regression analysis of the participants that reported a history of concussion. 
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Although this does not indicate a causal model, it does bring to light two different 
hypothesis as to why this occurred: one hypothesis is that individuals that reported a 
history of concussion respond differently than individuals that did not report a history of 
concussion on selected clinical tests. The second hypothesis is the sample of varsity level 
athletes was a majority of female and the literature tell us that females are more likely to 
report symptoms (Lovell et al, 2006) and are more likely to get concussed than their male 
counterparts in the same sport (Covassin, Swaink & Sachs, 2003) 
6.1 Case Study 
 Underlying all of the research in establishing a baseline measure in concussion 
and decisions for return to play has been the injury-recovery hypothesis (Appendix A). In 
this particular study we were able to observe the dynamics of an individual moving from 
baseline levels, to post injury levels and returning close to baseline estimates over time 
(Figure 6.2). The post injury decline, followed by the subsequent increase was inversely 
proportional to the reported symptoms of the concussed individual. The results shown 
here indicate that in the injury recovery hypothesis exists and that an individual will 
demonstrate deficits in the objective measures of HRV and CAS TEOAE following a 
concussion injury with a subsequent return to or near baseline over a period of time. 
While this is exciting in itself, we were unable to show this in a larger cohort for a 
number of reasons: first, athletes typically both underreport and don’t report injury 
(McCrea et al, 2004), they may not return to the clinic for post injury evaluation because 
it’s not part of the typical post injury regimen. There is a need for further post injury 
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assessment to further support the return to play hypothesis. As we saw in both phase 1 
and phase 2 of this study, there is high variability in the scores of HRV and in CAS 
TEOAE at baseline between individuals. It is important to have baseline estimates in 
order to properly assess the changes post injury as each individual case can have a 
different starting point. The significant difference in baseline scores could mean the 
different of a small decline post injury or a large one. Furthermore, concussion is 
associated with a stigma, especially in the athletic population, which leads to athletes 
self-diagnosing their recovery, and, in our case, choosing not to continue repeated testing 
once they were cleared to return to play. 
 
Figure 6.2The dynamics of the post-injury change in variables and return to baseline 
values over time (Montelpare, 2015) 
 
6.2 Limitations 
 There were limitations identified in this research. Although sex did not emerge as 
a predictor for any of the subscales of the DASS-21 and PASS-20, there was a larger 
number of females (n=52) compared to males (n=23) that completed the surveys and 
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baselines testing. Lovell et al reported that healthy young females report more symptoms 
compared to healthy young males (2006) at baseline and post injury. McFadden, Martin, 
Stagner & Maloney reported a difference in TEOAE responses, but only at higher 
frequencies, therefore data was analyzed at lower frequencies (2009). It should also be 
noted that symptoms, health status and the DASS-21 and PASS-20 were measured 
outside the clinic and there has been a tendency for athletes to under report symptoms as 
noted in the research by McCrea et al (2004). There are also noted limitations to the 
measurement of CAS TEOAE. In conducting the CAS TEOAE measurement researchers 
typically use a soundproof room or booth where the computer system and tester are 
located external to the testing space. In the present study the testing was completed in 
close proximity to measurement equipment and a soundproof space was unavailable. 
Likewise, this testing may have been influenced by external noises associated with 
concurrent testing in other spaces in the clinic. All CAS TEOAE data ran 260 data 
sweeps, but some participants had a larger number of data point rejected because of 
external noise and test duration was longer.  The attention to the CAS TEOAE linear 
click or broadband noise was not controlled. Research by De Boer & Thornton (2007) 
noted a change in suppression values based on whether participants were attentive to the 
sounds produced by the test or an arbitrary task. The effect of personal music devices was 
also controlled, using an otological questionnaire, based on self-report items may have 
been influenced by participant bias - with a possibility of underreporting. There are also 
some limitations for the measurement of HRV. The Polar Team2 Pro system and Kubios 
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Heart Rate Variability Analysis Software were used to evaluate the heart rate variability. 
These programs have been shown to provide reliable and stable estimates (Nunan et al, 
2009), however the researchers noted differences in the number of artefacts present in the 
r-r wave samples.  
 There is also a statistical limitation as it pertains to the McNemar chi-square and 
the Kappa test of agreement. This approach was chosen as the HRV data was non-
parametric and as such a non-parametric staticall approach was selected to best analyse 
the data. However, the CAS TEOAE data was analyzed in the same was, but the data is 
parametric, and was analysed the same in order to be consistent throughout the thesis.  
6.3 Conclusions and Recommendations 
 In conclusion, the objective measures of HRV and CAS TEOAE are comprised of 
sub-scale estimates that were considered to be stable measures. When assessing 
psychological measures of the DASS-21 and PASS-20, outcomes on the subscales can be 
predicted by LF/HF, mean heart rate and RMSSD. These relationships are considered to 
be present within a cohort reporting a history of concussion. When history of previous 
concussion was considered in our analysis, significant relationships differed and therefore 
it is concluded that concussion injury may influence clinical outcomes. Based on the 
results from the case study it is recommended that the use of the objective measures of 
HRV and CAS TEOAE as baselines and post injury measurements for concussion be 
explored further. It is also recommended that the predictability of the PASS-21 by 
variables of HRV be explored further using a longitudinal research design. The outcome 
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of the case study demonstrated the need for further data collection for the analysis of the 
injury recovery hypothesis. It also points out the need for a concussion protocol to be 
implemented and that protocols and services be linked with the health care team to better 
assess the injury and return to play timelines.  
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Appendix A 
Injury Recovery Hypothesis 
 
 
(Montelpare, et al., 2013) 
The injury-recovery hypothesis following concussion injury. 
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Appendix B 
Letter of Informed Consent 
UPEI Concussion Evaluation Clinic 
Establishing the test-retest stability of heart rate variability (HRV) and Contralateral 
Acoustic Suppression (CAS) in a sample of non-concussed college aged individuals 
Scheduled Appointment Time:                                                                                          . 
Please arrive on-time for your scheduled appointment.  We are located in the lower floor 
of the Steel Building (Room 128).   
Letter of Consent 
 
At the University of Prince Edward Island (UPEI), we are conducting studies on how to 
best detect concussion and manage the recovery process for individuals that experience 
such an injury. Currently, there is no comprehensive single strategy for establishing 
return to play following a concussion injury, as there are inconsistencies across sport type 
and age group. 
The purpose of our research is to examine the consistency for a series of non-invasive 
measures used to assess physical, and neurological function. We expect that the results of 
this work will contribute to decisions about an athlete’s return-to-play following a 
concussion injury. " 
Some basic guiding principles for the partnership between the researchers and the 
participants: 
I have read the information sheet for this study and have been given permission to print 
any information I wish. I have also been provided a contact number of the Principal 
Investigator and an invitation to ask questions about the study or my participation in the 
study. 
I understand that my participation is voluntary and that I am free to withdraw at any time 
without giving any reason, without my legal rights being affected. 
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I understand that I will not benefit financially if this study leads to the development of 
education and training or future research/education/technological developmental 
outcomes. 
I know how to contact the study team if necessary. I understand that I can contact the 
UPEI Research Ethics Board at (902) 620-5104, or by email at reb@upei.ca if I have any 
concerns about the ethical conduct of this study. 
I understand that by submitting the letter of informed consent with this study I am 
agreeing to participate in this study. 
I understand that a written summary of the findings will be available to participants 
through reports produced by the study team and disseminated via professional and 
academic journals and conferences. 
 
Authorization 
 
If you would like to participate in this research, please print this page and sign your name 
and date on the lines below. Please bring this form with you when you visit the UPEI 
Evaluation Clinic in the lower level of the Steel Building. This signed form is necessary 
for you to participate. 
I have read the information provided for the research conducted at UPEI related to 
establishing baselines for concussion screening as described in the associated information 
page. My questions have been answered to my satisfaction and I agree to participate in 
this study. I voluntarily choose to participate in this study, but understand that my consent 
does not take away my legal rights in the case of negligence or other legal fault of anyone 
who is involved in this study. I have been given a signed copy of this consent form. 
 
⁯ ☐By checking this box I am allowing any test results to be shared with UPEI 
healthcare professionals (ex. Physiotherapists or team doctors) or coaches 
☐By checking this box the participant indicates their interest of receiving study results at 
this email address                                __________________________________ 
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Name of Participant: _____________________________________ 
Signature: 
_____________________________________ 
DATE: ____________________________ 
On the day of your appointment please keep in mind these points: 
-The testing takes approximately 20 minutes 
-Sign and bring with you the attached “Letter of Consent”  
-Avoid listening to loud music  
If you have any questions or concerns please feel free to contact us at 
concussion@upei.ca 
Thank you for your co-operation and participation! 
 
 
 
Letter of Information 
Background Information  
 
Research about injuries sustained in sport and physical activities is not a new topic and 
despite the attention that various forms of media spotlight on catastrophic events in 
Signature of parent if participant is under the age of 18  
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sports, we still know very little about the true rate of injuries or effective strategies to 
reduce the risk of injury. A benefit of the recent attention to injury prevalence has been 
through the support of research into the causes, rates, and outcomes- both immediate and 
long term, to the effects of injury. As such, the purpose of this study is to use a 
prospective multiple cohort design to determine the most effective baseline testing and 
in-season screening with concomitant post-injury evaluation, for an athlete's readiness to 
return to activity following a traumatic brain injury (a concussion). 
  
Purpose 
The purpose of this study is to identify the statistical significance of Heart rate variability 
(HRV) and Contralateral acoustic suppression of transient evoked oto-acoustic emission 
(CAS TEOAE) as measurement of concussion. 
 
What is expected if I decide to participate? 
 If you choose to participate we will ask you to sign a consent form. After that you will 
schedule an appointment at the UPEI concussion evaluation clinic (Steele Room 
128).This study will have 25-30 participants, and take approximately 20 minutes per 
person to complete.  
 
CAS TEOAE assessment  
Participants will be seated, while a pair of small non-invasive probes similar to personal 
music system earphones will be placed in each ear canal (Otodynamics, UK) similar to 
personal music system earphones will be placed in each ear canal. CAS TEOAE 
measurements will be conducted following the default test paradigm employed by the 
Otodynamics ILO 292 otoacoustic emission analyzer (Otodynamics, UK). The test 
typically lasts approximately 2 minutes per ear and will not cause any harm to the 
participant. During TEOAE testing participants are asked to remain quiet and still. If any 
test results indicate the need for further audiological testing, participants will be given 
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appropriate advice and will have an opportunity to discuss any concerns with a registered 
audiologist. 
 
HRV assessment 
The proposed method for measuring heart rate variability  (HRV) will be based on those 
previously published in related studies (Berntson, Bigger, Eckberg, Grossman, et al, 
1997; Borella, Langbeinb, Desprésc, Hansen, et al, 2007). After the individual places the 
heart rate monitor strap across their chest, we will ask them to lie down on a standard 
reclining chair. After the individual has been resting in the supine position for 8 minutes 
we will be induce a response of the parasympathetic system by asking the person to stand 
from a lying position.  This approach is considered to be consistent with the 
recommended method in which an individual is asked remain in a supine resting position 
to allow for spectral and temporal analysis, followed immediately by a HRV 
measurement upon standing, which alters autonomic nervous system balance.  The HRV 
assessment will run simultaneously with the CAS TEOAE assessment. In total testing 
will take approximately 20 minutes in total.  
 
There are no known risks or harm associated with this research. 
Confidentiality 
All of the information collected will be kept strictly confidential. You will be assigned a 
personal identification number, to ID all of your data. Your ID and personal data will be 
stored on the University of Prince Edward Island firewall protected secure server that is 
only assessable with password. Your anonymous response will not be associated with 
your personal data once testing is completed. 
Results 
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If you so desire a summary of the findings from this research can be sent to you via 
email. Findings will be submitted for publication in peer reviewed ournals and present at 
academic and professional conferences.  
If you have any questions or concerns please contact  
Julia McKenna- Research Assistant- jpmckenna@upei.ca 
Professor William J. Montelpare, Ph.D., 
Margaret and Wallace McCain Chair in Human Development and Health, 
Department of Applied Sciences, Faculty of Science, 
Health Sciences Building, University of Prince Edward Island, 
550 Charlottetown, PE, Canada, C1A 4P3 
(o) (902) 620-5186 
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Appendix C 
 Otological Normality Questionnaire 
 
Participant’s Name: 
Participant’s Surname: 
Participant’s ID: 
 
Please Select your Varsity sport: Drop down menu  
 
Participant’s email 
 
Otological History 
 
Do you have any known hearing impairment? Y/N 
Have you had any operations on your ears? Y/N 
Do you have persistent tinnitus (ringing in ears)? Y/N 
Do you have any problems with your balance? Y/N 
 
Risk Factors 
Have you had any exposure to loud sounds within the previous 48 hours (e.g. occupational, 
recreational, gunfire)? Y/N 
Are you on any medication (ototoxic drugs)? Y/N 
Have you any family history of hearing impairment? Y/N 
How if your overall health? Very poor, Poor, Good, Excellent. 
 
Otological Examination (performed with an otoscope) 
Right EAM obstruction (e.g. wax, detritus, ++) ____________ 
Left EAM obstruction (e.g. wax, detritus, ++)____________ 
Right Pinna (e.g. No Abnormality Detected: NAD) ____________ 
Left Pinna (e.g. No Abnormality Detected: NAD) ___________ 
Right Tympanic membrane (e.g. No Abnormality Detected: NAD) ___________ 
Left Tympanic membrane (e.g. No Abnormality Detected: NAD) ___________ 
 
OAE Section  
SSOAE Right ear (Spontaneous otoacoustic emission) Y/N/Unsure 
SSOAE Left ear (Spontaneous otoacoustic emission) Y/N/Unsure 
 
Add Comments: ______________________________________________________ 
  
  
 
107 
Appendix D 
Depression Anxiety and Stress Scale-21  
(Lovibond & Lovibond, 1995) 
DASS 21    Name:                                                     Date: 
Please read each statement and circle a number 0, 1, 2 or 3 which indicates how much the 
statement applied to you over the past week.  There are no right or wrong answers.  Do not spend 
too much time on any statement. 
The rating scale is as follows: 
0  Did not apply to me at all 
1  Applied to me to some degree, or some of the time 
2  Applied to me to a considerable degree, or a good part of time 
3  Applied to me very much, or most of the time 
1 I found it hard to wind down 0  1      2   3 
2 I was aware of dryness of my mouth 0  1      2   3 
3 I couldn't seem to experience any positive feeling at all 0  1      2   3 
4 I experienced breathing difficulty (eg, excessively rapid breathing, 
breathlessness in the absence of physical exertion) 
0  1      2   3 
5 I found it difficult to work up the initiative to do things 0  1      2   3 
6 I tended to over-react to situations 0 1      2   3 
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7 I experienced trembling (eg, in the hands) 0  1      2   3 
8 I felt that I was using a lot of nervous energy 0  1      2   3 
9 I was worried about situations in which I might panic and make a 
fool of myself 
0  1      2   3 
10 I felt that I had nothing to look forward to 0  1      2   3 
11 I found myself getting agitated 0  1      2   3 
12 I found it difficult to relax 0  1      2   3 
13 I felt down-hearted and blue 0  1      2   3 
14 I was intolerant of anything that kept me from getting on with what I 
was doing 
0  1      2   3 
15 I felt I was close to panic 0  1      2   3 
16 I was unable to become enthusiastic about anything 0  1      2   3 
17 I felt I wasn't worth much as a person 0  1      2   3 
18 I felt that I was rather touchy 0 1      2   3 
19 I was aware of the action of my heart in the absence of physical 
exertion (eg, sense of heart rate increase, heart missing a beat) 
0 1      2   3 
20 I felt scared without any good reason 0  1      2   3 
21 I felt that life was meaningless 0  1      2   3 
 
  
 
109 
Appendix E 
Pain Anxiety Symptoms Scale-20 
(McCraken and Dhingra, 2002) 
 
Never                      Always 
1. I can't think straight when in pain 0 1 2 3 4 5 
2. During painful episodes it is difficult for me to think of anything besides 
the pain  0 1 2 3 4 5 
3. When I hurt I think about pain constantly 0 1 2 3 4 5 
4. I find it hard to concentrate when I hurt  0 1 2 3 4 5 
5. I worry when I am in pain 0 1 2 3 4 5 
6. I go immediately to bed when I feel severe pain 0 1 2 3 4 5 
7. I will stop any activity as soon as I sense pain coming on 0 1 2 3 4 5 
8. As soon as pain comes on I take medication to reduce it 0 1 2 3 4 5 
9. I avoid important activities when I hurt 0 1 2 3 4 5 
10. I try to avoid activities that cause pain 0 1 2 3 4 5 
11. I think that if my pain gets too severe it will never decrease 0 1 2 3 4 5 
12. When I feel pain I am afraid that something terrible will happen 0 1 2 3 4 5 
13. When I feel pain I think I might be seriously ill 0 1 2 3 4 5 
14. Pain sensations are terrifying 0 1 2 3 4 5 
15. When pain comes on strong I think that I might become paralyzed or 
more disabled 0 1 2 3 4 5 
16. I begin trembling when engaged in activity that increases pain 0 1 2 3 4 5 
17. Pain seems to cause my heart to pound or race 0 1 2 3 4 5 
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18. When I sense pain I feel dizzy or faint 0 1 2 3 4 5 
19. Pain makes me nauseous 0 1 2 3 4 5 
20. I find it difficult to calm my body down after periods of pain 0 1 2 3 4 5 
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Appendix F 
SAS Program for the Spearman Correlation Coefficient and Logistic 
Regression Analysis 
(Montelpare, 2015) 
options pagesize=55 linesize=135  date; 
LIBNAME Julia '/home/montelpare/public_html/Julia'; 
 
data Julia.July06; set Julia.June15MRG; 
 
ODS HTML BODY='july06reg-body.htm'  
         FRAME='july06reg-frame.htm' 
      CONTENTS='july06reg-contents.htm' 
          PAGE='july06reg-page.htm'; 
           
proc sort data=Julia.July06 noequals; by id; 
proc sort data=Julia.July06 noequals; by sex; 
 
proc freq; tables Depress Stress cog escape fear physio 
anxGroup; by sex; 
proc sort data=Julia.July06 noequals; by sex; 
 
proc logistic data=Julia.July06 descending; 
class sex  / param=ref ; model escapeGroup = lf hf lf_hf 
rmssd mnhr sex/rsquare noint; 
proc logistic data=Julia.July06 descending; 
class sex  / param=ref ; model escapeGroup = Y1414 SUM14 
X2000 SUM20 DIF20  sex/rsquare noint; 
 
proc logistic data=Julia.July06 descending; 
class sex  / param=ref ; model cogGroup = lf hf lf_hf rmssd 
mnhr sex/rsquare noint; 
proc logistic data=Julia.July06 descending; 
class sex  / param=ref ; model cogGroup = Y1414 SUM14 X2000 
SUM20 DIF20  sex/rsquare noint; 
 
 
proc logistic data=Julia.July06 descending; 
class sex  / param=ref ; model depGroup = lf hf lf_hf rmssd 
mnhr sex/rsquare noint; 
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proc logistic data=Julia.July06 descending; 
class sex  / param=ref ; model depGroup = Y1414 SUM14 X2000 
SUM20 DIF20  sex/rsquare noint; 
 
proc logistic data=Julia.July06 descending; 
class sex  / param=ref ; model strGroup = lf hf lf_hf rmssd 
mnhr sex/rsquare noint; 
proc logistic data=Julia.July06 descending; 
class sex  / param=ref ; model strGroup = Y1414 SUM14 X2000 
SUM20 DIF20  sex/rsquare noint; 
 
proc logistic data=Julia.July06 descending; 
class sex  / param=ref ; model fearGroup = lf hf lf_hf 
rmssd mnhr sex/rsquare noint; 
proc logistic data=Julia.July06 descending; 
class sex  / param=ref ; model fearGroup = Y1414 SUM14 
X2000 SUM20 DIF20  sex/rsquare noint; 
 
proc logistic data=Julia.July06 descending; 
class sex  / param=ref ; model anxGroup = lf hf lf_hf rmssd 
mnhr sex/rsquare noint; 
proc logistic data=Julia.July06 descending; 
class sex  / param=ref ; model anxGroup = Y1414 SUM14 X2000 
SUM20 DIF20  sex/rsquare noint; 
 
proc logistic data=Julia.July06 descending; 
class sex  / param=ref ; model physioGroup = lf hf lf_hf 
rmssd mnhr sex/rsquare noint; 
proc logistic data=Julia.July06 descending; 
class sex  / param=ref ; model physioGroup = Y1414 SUM14 
X2000 SUM20 DIF20  sex/rsquare noint; 
/* 
run; 
ods html close; 
 ods output close; 
 ods listing; 
 
run; 
 
 
 
